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Public Health Significance: Gynecologic cancers are responsible for millions of deaths 
worldwide every year. The goal of this research is to further scientific understanding of such 
cancers, potentially leading to improved diagnosis and treatment. The public health significance 
of this project is to uncover potential genetic underpinnings of gynecologic cancers, aiding in 
efforts to reduce the mortality rate of gynecologic cancers, which is imperative in protecting the 
health of susceptible persons across the globe. 
 
Gynecologic cancers are those which arise in the female reproductive system, chiefly, those 
of the ovaries, cervix, vulva, endometrium, and vagina. These conditions present a serious threat 
to the health of susceptible persons, leading to nearly three million deaths worldwide each year. 
Questions remain about the genetic origins and risk factors for each of them. Specifically, there is 
uncertainty regarding potential overlap in genetic architecture for these conditions. This analysis 
sought to answer the questions: are there shared genetic variants between ovarian cancers and 
endometrial and cervical cancers? If so, what are the genetic implications of these overlapping 
variants? This was accomplished by gathering summary-level data from published genome-wide 
association studies (GWAS) and analyzing them using fixed effects inverse variance meta-
analysis. Four datasets were included, three ovarian cancer datasets, one cervical and one 
endometrial cancer dataset. Three meta-analyses were performed: ovarian + endometrial cancer, 
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ovarian + cervical cancer, and ovarian cancer only. Several significant variants were found in the 
ovarian + endometrial cancer meta-analysis, including those located on genes TERT (p=3.1e-17), 
ABO (p=3.4e-11), and ATAD5 (p=3.7e-12). The ovarian + cervical cancer meta-analysis was 
inconclusive, but the ovarian-only meta-analysis provided evidence for significant variants across 
datasets, including those located on genes TIPARP (p=2.3e-14) and SKAP1 (p=3.0e-10). Some 
variants found may yield new insight if studied in conjunction with both types of cancer in the 
meta-analysis, such as ABO for endometrial cancer, a known genetic factor in ovarian cancer risk. 
Further study is needed to determine the relevance and level of involvement for shared genetic 
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Gynecologic cancers are a class of cancers that affect people susceptible to cancers of the 
ovaries, cervix, endometrium, vulva, and vagina (i.e., those with female reproductive organs), and 
result in approximately 2.9 million cancer deaths every year globally (Sankaranarayanan and 
Ferlay, 2006). Specific to the United States, the incidence of gynecologic cancers is approximately 
40 diagnoses and 12.5 deaths per 100,000 susceptible people per year (Phelan et al., 2017). As 
such, these cancers pose a serious threat to the health of susceptible people. Each of these cancers 
has been well researched singularly. However, the similarities and differences of the underlying 
sub-types of gynecologic cancers are not fully understood. That is, there may be commonalities in 
the mechanisms of gynecologic cancers in terms of tumorigenesis, genomic makeup, etc., that are 
currently not characterized in the body of literature. Investigating such commonalities may lead to 
improved or new methods of treatment or prevention for gynecologic cancers. 
1.1 Distinct Characteristics of Gynecologic Cancer Sub-Types 
Examining the overlapping characteristics of gynecologic cancers necessitates 
understanding the etiologic and prognostic differences across sub-types. Cervical cancer, for 
example, is thought to arise virtually always in cases of individuals with human papillomavirus 
(HPV) (Ledford and Lockwood, 2019). Contrasted to cervical cancer, endometrial cancer is 
thought to be attributed to imbalances in hormone regulation, as high body mass index is a risk 
factor for development of endometrial cancer; this is potentially due to the role of adipose tissue 
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in circulating estrogen in post-menopausal women, promoting endometrial growth (Guo et al., 
2020; Ledford and Lockwood, 2019; Schmandt et al., 2011). The causes of ovarian cancers are 
less clearly understood; some are hypothesized to be related to endometriosis and others could 
arise in the fallopian tube epithelium (Zorn et al., 2005; Guo et al., 2020). Vaginal and vulvar 
cancers are rarer, both of which are related to HPV (Ledford and Lockwood, 2019). Prognosis also 
varies across gynecologic cancer sub-types. Ovarian cancer is more deadly than the other four 
gynecologic cancers, which is speculated to be due to late diagnosis times (i.e., higher severity of 
cancer stage at time of discovery) (Ledford and Lockwood, 2019). Ledford and Lockwood (2019) 
estimated that ovarian cancer accounted for approximately 14,000 deaths in 2018, compared to 
endometrial cancers at approximately 11,000, and the other three types accounting for less than 
5,000 deaths in the United States, based on 2018 estimates (Ledford and Lockwood, 2019). 
According to a literature review of gynecologic cancer clinical outcomes and association with 
genetic polymorphisms, as reported by Diaz-Padilla et al. (2012), no consistent associations were 
repeatedly observed by searching databases including EMBASE, MEDLINE, and Cochrane for 
specific gene polymorphisms and cross-phenotype outcome (Diaz-Padilla et al., 2012). 
1.2 General Commonalities Across Gynecologic Cancer Sub-Types 
 While each of the five cancers vary in cellular makeup and physical location of tumor, 
there have been some overall similarities observed between sub-types of gynecologic cancer. For 
example, all types of gynecologic cancers originate in the Mullerian ducts and are affected by 
female sex hormones (Berger et al., 2018; Guo et al., 2020). Endometrial and some ovarian cancers 
have been associated with Lynch syndrome, and cervical cancers and some ovarian cancers have 
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been associated with Peutz-Jeghers syndrome (Constantinou and Tischkowitz, 2017). Lynch 
syndrome is passed down through an autosomal dominant trait, with an approximate prevalence 
of 1:370 for susceptible populations globally, though not each case of Lynch syndrome results in 
the development of a carcinoma (Constantinou and Tischkowitz, 2017). Lynch syndrome is 
thought to develop by mutations in DNA repair genes MLH1, MSH2, MSH6 and PMS2 
(Constantinou and Tischkowitz, 2017). Lynch syndrome has been associated with a number of 
cancers, generally, associated cases of which demonstrate microsatellite instability, redundant 
sequences which cause replication errors (Constantinou and Tischkowitz, 2017). 
 
Wang et al. (2018) examined the role of driver genes across ovarian, cervical, and 
endometrial cancers by functional enrichment and pathway analysis. The authors found four 
differentially expressed genes to be noteworthy across the prognoses of the three cancer types, 
including lowered expression of MCM2 (all sub-types), elevated expression of MMP2 (primarily 
cervical), elevated expression of COL1A1 (primarily ovarian), and elevated expression of JUN 
(primarily ovarian and endometrial) (Wang et al., 2018). Another study examined expression 
levels of FAS and FAS-ligand across ovarian, endometrial, and cervical carcinoma tissue, 
demonstrating decreased levels of FAS gene expression in all three sub-types compared with non-
cancerous cell tissue (Das et al., 2000). Further, Zorn et al. (2005) assessed differential expression 
profiles of serous, endometrioid, and clear cell histotypes of ovarian and endometrial cancer. The 
authors found several common differentially expressed genes across ovarian and endometrial 




A whole-exome study in 209 Chinese gynecologic cancer patients (specifically, ovarian, 
endometrial, and cervical cancer) demonstrated some commonalities across the three cancer types 
(Guo et al., 2020). Primarily, the authors identified mutations in the cancer-associated gene 
PIK3CA across all three types studied (122/209, 58% of cases studied) (Guo et al., 2020). Other 
tumor associated gene mutations were also observed, including PTEN, TP53, CDC27, ZFHX3, 
MUC16, ARIDIA, KMT2C, KRAS, and BRCA2, which were observed in 9% to 25% of overall 
cases across the total sample (Guo et al., 2020). Further, Guo et al. reported that MUC16/CA125, 
associated with an ovarian cancer biomarker protein, was mutated in 20% of endometrial cancer 
cases, 29% of cervical cancer cases, and 12% of ovarian cancer cases, as well as the cilia motility 
associated gene HYDIN mutated in 43% (90/209) of the total sample (Guo et al., 2020).   
 
Guo et al. (2020) also assessed copy number variants (CNVs) across the 209 Chinese 
endometrial, cervical, and ovarian cancer patients cohort. Specifically, the authors identified two 
amplified regions (12p13.33 (75/209), 15q26.3 (33/209)) and two deleted regions (9p24.3 
(69/209), 11p15.5 (47/209)) across the three cancer types (Guo et al., 2020). The amplified regions 
covered retinal coding proteins and the deleted regions covered tumor suppressor genes (Guo et 
al., 2020). 
 
Additionally, Guo et al. described molecular similarities between the three cancer types. 
Specifically, they described evidence in each cancer sub-type for DNA mismatch repair 
deficiencies, noted by mutation signature (Guo et al., 2020). They further demonstrated a number 
of shared enriched biological pathways across cancer types, two of which were associated with 
cilia movement (GO:0044782, GO:0001539), one associated with chromatin modification 
 
5 
(GO:0016569), and a number associated with cell or tissue morphogenesis (GO:0022604, 
GO:0002009, GO:0003007) and cellular organization (GO:0098742, GO:0034330) (Guo et al., 
2020: Supplementary Table 3). 
 
Berger et al. (2018) also examined the molecular properties of gynecologic cancers, 
specifically, ovarian, cervical, and uterine/endometrial cancers using Cancer Genome Atlas data 
(TCGA). They found 23 genes that were more frequently mutated in gynecologic cancers 
compared with other TCGA cancer types via enrichment, including FBXW7, PIK3CA, PIK3R1, 
TP53, and PTEN (Berger et al., 2018). The authors additionally performed hierarchical 
unsupervised clustering on tumor mutation signatures, resulting in ten distinct clusters. Two of the 
clusters were associated with mutations related to DNA mismatch and strand repair (Berger et al., 
2018). Another cluster showed a high number of microsatellite instability mutations (primarily 
uterine/endometrial samples), and another showed a high number of APOBEC mutations 
(primarily cervical samples) (Berger et al., 2018). The authors additionally performed hierarchical 
clustering over CNVs, resulting in six clusters, two of which were associated with TP53 mutations, 
and the majority of samples in these two clusters at least one whole genome doubling event (Berger 
et al., 2018).  
 
Lastly, Zhang et al. (2018) performed a meta-analysis across case-control studies of 
gynecological cancers that included one or both of two gene promoter polymorphisms, MDM2 
T309G and/or MDM2 G285C. The authors found the risk of gynecologic outcome was increased 
or decreased, in both polymorphic cases, depending on the underlying genotype at those locations 




There also exists some evidence of multiple types of gynecologic cancers synchronously 
manifesting in the same individuals. Specific to ovarian and endometrial cancers, co-occurrence 
arises in approximately 5% of endometrial cancer cases and 10% of ovarian cancer cases (Takeda 
et al., 2018). Herrinton et al. (2001) reviewed three population-based case-control studies across 
56 women presenting synchronous ovarian and endometrial tumors (Herrinton et al., 2001). 
Specifically, the participants in the underlying studies were those that were diagnosed with both 
cancers within a 12-month period and were between 20 and 54 years of age (Herrinton et al., 2001). 
The authors found that, compared with only ovarian cases, participants with both ovarian and 
endometrial cancers were more likely to have endometrioid (43% observed, 10% expected) and 
less mucinous (31% observed, 54% expected) ovarian cancers (Herrinton et al., 2001). Takeda et 
al. (2018) examined one synchronous ovarian and endometrial case with Lynch syndrome, and 
reported that this case exhibited microsatellite instability as well as reduced MSH2 and MSH6 
expression in both tumors (Takeda et al., 2018). There is also evidence of ovarian and cervical 
tumor synchronicity, however, cases are rare and isolated (Bacalbasa et al., 2020). 
 
As such, there is foundational evidence suggesting a number of both shared and unique 
traits among sub-types of gynecologic cancers. The most obvious contrast between all the sub-
types is the ultimate location of tumor growth, but there are a number of shared genes that have 
been associated with more than one type of gynecologic cancer. For instance, Berger et al. (2018) 
and Guo et al. (2020) both identified the PTEN and TP53 genes in some association with ovarian, 
endometrial, and cervical cancers. And, while co-occurrences are rare, the presence of 
synchronous cases further indicates that there may be specific similarities affecting multiple 
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phenotypes of gynecologic cancer arising due to a similar genetic or environmental risk factor. 
There are some genes that potentially may be associated with such cancers but have not yet been 
identified in association, presenting an opportunity for study.  
1.2.1 Genome-Wide Association Commonalities Across Sub-Types 
Masuda et al. (2020) conducted a genome-wide association study (GWAS) meta-analysis 
across 647 ovarian cancer cases, 909 endometrial cancer cases, 538 cervical cancer cases, 5236 
cases of uterine fibroid, and 645 cases of endometriosis from the Biobank Japan Project (39,556 
controls). They specifically conducted random-effects meta-analyses for individual case groups 
and respective controls, then compared these with both logistic and linear-mixed regression models 
across all cases and shared controls. Additionally, the authors performed reverse regression 
analysis on imputed genotypes and covariate-adjusted phenotypes, such that phenotypes were 
assembled in the best combination to maximize log-likelihood estimates, with covariates including 
age, squared-age, BMI, and the top 20 principal components. They found one genome-wide 
significant locus by conducting random effect meta-analysis on the linear mixed model summary 
statistic results (LOC730100, OR: 1.16 (95% CI: 1.01-1.33), p=2x10-8) of three conditions 
(ovarian cancer, endometrial cancer, and endometriosis) (Masuda et al., 2020). Three genome-
wide significant loci were detected by reverse regression analysis (GABBR2, p=4.8x10-8; 
SH3GL3/BNC1, p=3.3x10-8; LOC107985484, p=3.8x10-8), however, only the last locus included 




1.3 Research Question 
There is some genetic and molecular evidence that gynecologic cancers are related to some 
degree. These shared properties may present enormous opportunities in future research of detection 
and treatment for gynecologic cancers. However, what is missing is a robust amount of data on 
shared genetic properties in a genome-wide context. This is an important gap to fill, and genome-
wide association studies can be used to address this gap, as they assess the frequency of variants 
across the genome in a large number of cases and controls for a particular disease outcome. The 
variant-outcome results can then inform previously unrelated or undiscovered biological 
mechanisms and risk factors for the specific outcome. These results can be translated into more 
practical or effective medical treatments. The Masuda et al. (2020) study is one of few cross-
phenotype meta-analyses over genome-wide gynecologic cancer data, and perhaps the only study 
assessing more than two gynecologic phenotypes in a genome-wide context.   Specifically, GWAS 
analyses have built a foundation for personalized medical care, that is, treatments and therapies 
tailored to a patient’s specific genome-wide makeup. Particularly, as it relates to pleiotropy, 
GWAS analyses have demonstrated that the same variant or variants can be associated with 
multiple phenotypic outcomes across cohorts (Li and Zhu, 2017; Visscher et al., 2017). However, 
the relationship between shared variants identified by GWAS results and biological implications 
is not always clear, necessitating further investigations from a genetic and molecular standpoint. 
Many of the variants identified in GWAS analyses are located in non-coding regions, so combining 
GWAS results with functional analyses can grant insight on the mechanisms by which specific 




As such, the focus of this analysis is to identify shared genetic association signals within 
ovarian cancer as well as between cancer groups (ovarian + cervical and ovarian + endometrial). 
This will be accomplished using publicly available data from genome-wide association studies in 
the form of de-identified summary-level data, for each variant across studies to determine shared 





2.1 Datasets Included 
Datasets were identified by searching the GWAS Catalog 
(www.ebi.ac.uk/gwas/downloads/summary-statistics) for available sets of data containing the 
keywords “ovar”, “cerv”, and “endo”. Additionally, to identify available summary statistic 
datasets from existing publications not included in the GWAS Catalog, PubMed was queried 
with the keyword phrases “(((gynecol*) AND (cancer)) AND (gwas)” as well as “ovar*”, 
“endo*”, and “cerv*” variations for ‘gynecol*’, but no additional datasets were identified that 
met the inclusion criteria (described below) and did not overlap with already identified studies. 
To identify existing meta-analyses of gynecologic GWAS results, the keyword set (((meta) AND 
(gynecol*)) AND (cancer)) AND (gwas) was also queried in PubMed.  
 
To be included in these meta-analyses, studies must have assessed a gynecologic cancer 
via GWAS, with available accompanying summary statistic packages in complete form, including 
translatable regression statistics (i.e., beta coefficients measuring the magnitude of effect, as well 
as associated standard errors and p-values), both alleles per variant with allele frequencies, and  not 
overlapping samples with other included studies. This was the case for two studies (Rashkin et al., 
2020 and UK Biobank (2018)), so Rashkin et al. was excluded; Rashkin et al. (2020) was further 
missing allele frequencies, presenting an issue with preparing the data. An additional source did 
not provide comprehensive study information (Leo et al., 2017), so it was excluded on this basis. 
As such, exclusion criteria were studies with incomplete summary statistic packages (either 
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missing alleles and/or frequencies, or untranslatable analysis statistics in the form of something 
other than a beta value or log odds ratio), or studies without freely available or any complete 
summary statistic results, resulting in the two study exclusions above.  
 
Phelan et al. (2017) assessed data from the Ovarian Cancer Association Consortium 
(OCAC), as well as data from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), 
including 25,509 epithelial ovarian cancer cases and 40,941 controls in European ancestry women 
for GWAS analysis (Phelan et al., 2017). Histotypes of epithelial ovarian cancer that the authors 
studied included all invasive, serous invasive, high grade serous, low grade serous, mucinous, 
endometrioid, and clear cell carcinomas (Phelan et al., 2017). Genotyping for this study was 
performed by OncoArray and iCOGS at five sites, University of Cambridge, Center for Inherited 
Disease Research, National Cancer Institute, Genome Quebec and Mayo Clinic (Phelan et al., 
2017). Genotyping QC was conducted by excluding samples with call rate 95%, low or high 
heterozygosity, samples that were not female, or duplicates (Phelan et al., 2017). They further 
applied QC measures on SNPs including those with call rate < 95%, those not in Hardy-Weinberg 
equilibrium, and those with < 98% concordance (Phelan et al., 2017). Imputation was performed 
for any region with a SNP with p-value < 10-6 using the 1000 Genomes Project reference panel 
(v3, October 2014), and by employing the IMPUTE2 method, with boundaries at +/- 500kb from 
the most significant regional SNP, with exclusion of imputed variants or accuracy r2 < 0.3, or 
minor allele frequency < 0.01 (Phelan et al., 2017). Association analyses were conducted 
separately for both data sources, categorizing the disease outcomes as:  all invasive disease, high 
grade serous, low grade serous, all invasive serous, serous borderline, low grade serous + 
borderline, endometrioid, clear cell carcinoma, or mucinous invasive + mucinous borderline 
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(Phelan et al., 2017). For OCAC, initial genome-wide analyses performed on each of the 
underlying studies were meta-analyzed by inverse variance fixed effects, adjusted for study and 
population substructure. After imputation for genotype in regions of interest, logistic regression 
was performed, adjusting for genotype-study combination and principal components (Phelan et 
al., 2017). For CIMBA data, the underlying studies were assessed by fixed effect meta-analysis, 
and a time-to-cancer survival analysis framework was further implemented. To address non-
random sampling between BRCA1 and BRCA2 carriers, test statistic scores of retrospective 
likelihood were employed to assess the association between genotype and risk of ovarian cancer 
(Phelan et al., 2017). Both CIMBA and OCAC data were pooled in an inverse variance fixed 
effects meta-analysis (Phelan et al., 2017). 
 
Lawrenson et al. (2019) meta-analyzed data from 63 studies under the OCAC, compiling 
7,321 cases and 4,083 controls of Asian ancestry descent individuals (Lawrenson et al., 2019). 
Similarly, genotyping for this study occurred by OncoArray at one of five sites: University of 
Cambridge, Center for Inherited Disease Research, National Cancer Institute, Genome Quebec and 
Mayo Clinic (Lawrenson et al., 2019). Genotyping QC was characterized by excluding samples 
with call rate < 95%, low or high heterozygosity, samples that were not female, and duplicates 
(Lawrenson et al., 2019). Phenotypic outcomes were categorized as one of the following histotypes 
of epithelial ovarian cancer: high grade serous, low grade serous, endometrioid, clear cell, 
mucinous, ‘other’, borderline serous, and borderline mucinous (Lawrenson et al., 2019). Similarly, 
SNP QC was characterized by excluding SNPs with call rate < 95%, those not in Hardy-Weinberg 
equilibrium, those with concordance < 98%, those with minor allele frequency < 0.01, or those 
with imputation accuracy r2 < 0.3 (Lawrenson et al., 2019). Imputation was executed by using the 
 
13 
1000 Genomes Project reference panel, and using the IMPUTE2 method (Lawrenson et al., 2019). 
Boundaries were set for +/- 500kb from the most significant regional SNP (Lawrenson et al., 
2019). Initial genome-wide analyses were conducted for each of the datasets included, the results 
of which were meta-analyzed by fixed effects (Lawrenson et al., 2019). Following imputation, a 
simple logistic regression model was used, adjusting for genotype-study combination and principal 
components; association analyses were conducted for all histotypes, all invasive, all borderline, 
and each histotype individually (Lawrenson et al., 2019). Confounding by population substructure 
was addressed by calculating inflation in test statistics (Lawrenson et al., 2019). 
 
O’Mara et al. (2018) meta-analyzed endometrial cancer data from 13 individual studies, as 
well as 45 additional consortia studies, to perform genome-wide association. The authors did not 
report specific criteria for phenotypic classification. Underlying consortium sources included the 
Endometrial Cancer Association Consortium (ECAC), Epidemiology of Endometrial Cancer 
Consortium (E2C2), Women’s Health Initiative, and UK Biobank Round 1 results; as such, the 
O’Mara dataset was not included in analyses with the UK Biobank data sources (O’Mara et al., 
2018). In total, they meta-analyzed 12,906 endometrial cancer cases and 108,979 matched controls 
of European ancestry descent. Genotyping was performed by OncoArray at one of two sites, The 
Center for Inherited Disease Research or the University of Melbourne; data from the E2C2 were 
genotyped by Illumina Human OmniExpress array and Illumina Human 660W array, while the 
data from the Women’s Health Initiative were genotyped on five different arrays (O’Mara et al., 
2018). The UK Biobank data were genotyped using the Affymetrix UK BiLEVE Axiom array and 
Affymetrix UK Biobank Axiom array (O’Mara et al., 2018). Genotyping QC was performed by 
removing samples with call rate < 95%, low or high heterozygosity, estimated European ancestry 
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< 80%, or those that were suspected to be from non-female individuals (O’Mara et al., 2018). SNP 
QC was performed by removing SNPs with call rate < 95%, those violating Hardy-Weinberg 
equilibrium, those with concordance < 98%; before imputing, SNPs with minor allele frequency 
< 0.01 and those with concordance < 98% were excluded (O’Mara et al., 2018). For the OncoArray 
data, imputation was performed using the 1000 Genomes Project reference panel, via the 
SHAPEIT2 method, with boundaries set at 5mb non-overlapping intervals (O’Mara et al., 2018). 
Data from the E2C2 were imputed by using the 1000 Genomes reference panel, and Women’s 
Health Initiative were imputed by using both 1000 Genomes and UK10K reference panels, both 
by using the minimac2 software (O’Mara et al., 2018). The UK Biobank data were imputed by 
using both 1000 Genomes and UK10K reference panels, and the SHAPEIT3 and IMPUTE3 
services (O’Mara et al., 2018). Logistic regression was used to model the associations between 
each of the datasets (to a total of 17 strata) and the outcome, adjusting for principal component 
relative to dataset (O’Mara et al., 2018). Population substructure was addressed by computing test 
statistic inflation, and the resulting effect estimates were combined in a fixed effects inverse 
variance meta-analysis (O’Mara et al., 2018).  
 
The UK Biobank study, a large prospective cohort study, is an ongoing study collecting 
genotypic and phenotypic data on over 500,000 individuals of European descent (Abbott et al., 
2018; Sudlow et al., 2015). For this analysis, the Round 2 results were used for both cervical cancer 
and ovarian cancer separately, which included 691 cases of ovarian cancer and 193,483 controls, 
and 192 cases of cervical cancer and 193,982 controls, respectively (Abbott et al., 2018). Samples 
were genotyped by the UK BiLEVE Axiom Array by Affymetrix and Applied Biosystems UK 
Biobank Axiom Array (Bycroft et al., 2018). Genotype QC measures included extensive 
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missingness and heterozygosity, and samples that were not female (Bycroft et al., 2018). Variant-
based QC measures including testing for batch effects, plate effects, violation of Hardy-Weinberg 
equilibrium, sex effects, array effects, and discordance in control replicates (Bycroft et al., 2018). 
Imputation was performed using a custom version of IMPUTE2 with 250 kb buffer regions 
(Bycroft et al., 2018). Association tests to generate summary statistics were performed by least-
squares linear modeling using disease or phenotype as the outcome predicted by additive genotype, 
with sex and the first 10 principal components as covariates (Howrigan et al., 2017). 
 
After excluding studies not meeting inclusion criteria, the above four data sources 
remained. Two ovarian cancer studies (Phelan et al. 2017, Lawrenson et al. 2019) were used in all 
three analyses, while the endometrial cancer dataset (O’Mara 2018) was used in the 
ovarian+endometrial (‘o+e’) cancer meta-analysis, the UK Biobank ovarian cancer dataset was 
used in the ‘ovarian only’ (‘o-o’) cancer meta-analysis and the UK Biobank cervical cancer dataset 
was used in the ovarian+cervical (‘o+c’) cancer meta-analysis. Lastly, because the O’Mara dataset 
was reported in the genome build ‘hg38’, in order to properly align markers with the other datasets 
under meta-analysis, this data was converted to the genome build ‘hg19’ using the tool LiftOver 
(https://genome.ucsc.edu/cgi-bin/hgLiftOver), due to the other datasets having been reported in 
the ‘hg19’ build. Build conversion via LiftOver (available through the UCSC genome browser 
web tool) was accomplished by uploading the chromosome, position start, and position end data 
along with the marker name to match the LiftOver product to the existing O’Mara data (Kent et 
al., 2002). The position start component was populated by subtracting the ‘position’ field in the 




2.2 Data Processing 
 
The data for these analyses was obtained from five sources (including two distinct 
phenotypes from the same consortia): three with ovarian cancer data (Phelan et al., 2017; 
Lawrenson et al., 2019; UK Biobank, 2018), one with endometrial cancer data (O’Mara et al., 
2018), and one with cervical cancer data (UK Biobank, 2018). First, the summary statistic result 
files were downloaded from either the GWAS Catalog 
(www.ebi.ac.uk/gwas/downloads/summary-statistics) or the Neale Lab data repository (for data 
from the UK Biobank) (Buniello et al., 2019; Abbott et al., 2018). Each set of summary statistic 
files contained resulting GWAS statistics from an individual study including the following 
information for each variant, at a minimum: chromosome, physical chromosomal position, beta 
regression coefficient or log odds ratio, standard error, reference or baseline allele, minor or 
effect allele, and minor or effect allele frequency. Files were organized and quality-controlled 
SNP-wise using RStudio (R Core Team, 2020). Summary statistic files were read into RStudio in 
their base form, and subsetted by chromosome (or, in the case of per-chromosome files, simply 
read in one chromosome at a time). Because not all files contained rsID information, SNP names 
were constructed by combining chromosome and position (in the GRCh37 human genome 
assembly), separated by ‘:’, to harmonize between datasets. Quality-control measures included 
removal of SNPs in each dataset followed these criteria: SNPs with negative p-values as well as 
p-values greater than 1, SNPs with negative standard error, and SNPs with minor allele 
frequency less than 0.01 (or effect allele frequency less than 0.01 or greater than 0.99). Details 






Figure 1: Flowchart of data from identification to assessment 
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2.3 Analysis Steps 
Studies were meta-analyzed using the command line tool METAL (version 2011-03-25). 
METAL utilizes standard p-value-based or inverse variance-based methods for genetic meta-
analysis. For this analysis, the inverse variance method was employed to preserve the interpretation 
of the estimated effect sizes. The equations that are used by METAL to compute the pooled effect 
estimates for inverse variance method are shown below (Willer et al., 2010). Scripts were written 
and used by METAL in accordance with the documentation for selecting the standard error 
scheme. Information included in each script about each dataset and dataset inputs included SNP 
marker name, reference/baseline and effect/minor allele, p-value, beta or log odds ratio, separator 
of .txt file, and standard error. Resulting files, per chromosome from METAL runs, were then read 
into RStudio and combined into results files per meta-analysis. 
2.4 Fixed Effects Inverse Variance Meta-Analysis 
The METAL software uses four mathematical steps to accomplish fixed effects meta-
analysis under the inverse variance paradigm. The below equations represent the modeling 
performed in fixed effects methods.  
(1.1) 𝑍 =  𝛽/𝑠𝑒 
where 
(1.2) 𝛽 =  ∑ 𝛽𝑖𝑖 𝑤𝑖/ ∑ 𝑤𝑖𝑖  
and 





(1.4) se = √1/ ∑ 𝑤𝑖𝑖  
For each study contributing to the meta-analysis, Z-scores are calculated by dividing the 
pooled effect size, 𝛽, by the pooled standard error, 𝑠𝑒 (1.1). In the remaining equations, the term 𝑖 
represents the studies included. To that end, if a variant was present only in one study, it was 
processed by METAL (with no pooling but using that variant’s standard error) and excluded after 
reading the files back into RStudio, because that variant is not informative under the meta-analysis. 
The pooled effect size is calculated by summing the product of the per-study effect size, 𝛽𝑖 with 
the per-study weight, 𝑤𝑖, then dividing it by the sum of the per-study weights (1.2). The per-study 
weight is calculated by taking the reciprocal of the corresponding study squared standard error 
(1.3). The pooled standard error is represented in equation 1.4, where the reciprocal of the per-
study weight is summed and evaluated under a square root. Because the inverse variance method 
does not adjust for between-study variance, this method falls under a fixed effects method. Fixed 
effects methods are based on outcomes or phenotypes wherein there is no significant heterogeneity 
across all studies; that is, when combined under meta-analysis, each trial is assumed to share a 
common effect, such that the overall effect size is a true estimate of the common effect (Zhu et al, 
2018; Li and Zhu, 2017). However, when there is considerable heterogeneity between studies, a 
random effect is generally used, which accounts for heterogeneity between studies. Random 
effects inverse variance models incorporate a second source of variance, between-dataset variance, 
𝜏2, as shown below in Equation 1.5, which reflects the difference in effect sizes across input studies 
based on the scale of effect (Borenstein et al., 2010). 
 
(1.5) 𝑤𝑖 = 1/(𝑠𝑒𝑖




In this analysis, a fixed effect inverse variance paradigm was selected, though each method 
confers both benefits and disadvantages. First, compared to random effects, fixed effects methods 
optimize the discovery rate (at the consequence of allowing higher false discovery rates, i.e., Type 
I error) for cross-phenotype SNP associations, as random effects models are much more 
statistically conservative and have limited power (Evangelou and Ioannidis, 2013; Pereira et al., 
2009; Zhu et al., 2018). Because some of these analyses examined cross-phenotype genomic 
associations across ancestry groups, maximum power was desired, so that any possible SNPs 
associated with the cancer types could be elucidated, and then investigated for real genetic basis 
for association with both phenotypes. It has been indicated that fixed effects models may be more 
powerful than random effects models, even in the presence of considerable heterogeneity (Zhu et 
al., 2018; Pereira et al., 2009). This leads to the second point: because of the conservative statistical 
significance threshold in GWAS analysis, the number of loci that are significantly related to the 
outcome are generally low (Zhu et al., 2018). Further, random effects methods suffer from 
unreliable results (due to unreliable between-study variance when pooling effects) when the 
number of input studies is low (Guolo and Varin, 2017; Lin et al., 2020). As such, given the 
acceptance of some false positives (Type I error) in the goal of large-scale exploration and 
discovery, and the application of fixed effects methods to cross-phenotype data (with the 




2.5 Additional Steps and Considerations 
METAL also calculates heterogeneity within SNPs across datasets, shown below. While 
this is not incorporated into the models themselves, it is still useful to assess the between-dataset 
heterogeneity, per SNP, to quantify the variance between datasets. This is conducted through the 
I2 statistic, which translates Cochran’s Q (chi-squared statistic) into a percentage of heterogeneity 
between studies, as shown in Equation 2.1, where Q is the statistic following a chi-square 
distribution with (n – 1) degrees of freedom based on the number of datasets included in the models 
(Higgins et al., 2021). 
 
(2.1) 𝐼2 = ((𝑄 − 𝑑𝑓)/𝑄) ∗ 100% 
 
In contrast to 𝜏2, the I2 coefficient is the proportion of observed variation relative to 
differences in effect sizes (Borenstein et al., 2009). The percentages themselves do not necessarily 
represent objective heterogeneity, for several reasons, but particularly because chi-squared tests 
are not very powerful for small sample meta-analyses. Generally, 0% to 40% heterogeneity may 
not be important, 30% to 90% may represent moderate to substantial heterogeneity, and 75% to 
100% may represent significant heterogeneity. Though fixed effects methods assume no 
significant heterogeneity between studies, reporting significant variants with significant 
heterogeneity is important because it may inform further follow-up analysis, as it is possible that 
identified significant variants are linked to true causal variants but exhibit heterogeneity, which 
can be explored by techniques such as fine mapping (Ioannidis et al., 2007). Fine mapping involves 
the identification of causal variants by considering genes related to the outcome and examining 
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variants that are linked to those found significant by genome-wide association, but themselves do 
not reach genome-wide significance (Ioannidis et al., 2007). 
 
Resulting files from METAL were uploaded to LocusZoom (my.locuszoom.org), an online 
service for visualization of GWAS results. Each meta-analysis, as well as each dataset that was 
entered into a model, was separately uploaded and stored. For each, Manhattan plots, QQ plots, 
and regional association plots were generated. Manhattan plots present the -log10 p-value for each 
SNP in chromosomal order, while regional association plots demonstrate the same information but 





3.1 Individual Study Results 
In total, there were between 9 and 20 million SNPs per each of the data sources, and 
approximately 9 million SNPs per meta-analysis uploaded to LocusZoom after filtering (Figure 
1). Many of the variants were lost to having minor allele frequency < 0.01, as well as during meta-
analysis, as several markers were either duplicates of other markers (in name) or were excluded 
based on having different effect and/or baseline alleles compared to other studies with the same 
marker. It is important to reiterate that each meta-analysis contained one individual study as well 
as the Phelan (2017) and Lawrenson (2019) studies when considering the number of variants that 
were meta-analyzed.  
 
Graphical results, including Manhattan and quantile-quantile plots, for the individual 
studies uploaded to the LocusZoom tool are shown in Figures 2A-2J; these uploaded datasets were 
the filtered versions used in the meta-analyses. Nearest genes to SNPs with the highest negative 
log-p-value per significant locus are annotated on the Manhattan plots by LocusZoom. Overall, 
the results of individual studies reflect those presented in the respective publications. For instance, 
the O’Mara (2018) Manhattan plot and the uploaded data in Figure 2A appear visually similar, 
with a few discrepancies. Specifically, both exhibit the nearly the same pattern of significant SNPs 
along chromosomes 6, 8, 15, and 17, however, the results presented in Figure 2A do not show 
significant SNPs on chromosomes 2 or 11 (O’Mara et al., 2018; Figure 2A). This can be explained 
by the filtering steps prior to using this data in the meta-analysis. While the Phelan (2017) and 
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Lawrenson (2019) studies did not report overall Manhattan plots, the results in Figures 2C and 2E 
are consistent with the results reported by the respective authors, again considering the results 
presented here were post-filtering. At present, there are no published GWAS results for cervical 
and ovarian cancers from the UK Biobank data repository. Genomic control lambdas for the 
quantile-quantile plots were, at the median for each set, 1.087 (O’Mara), 1.054 (Lawrenson), 1.054 
(Phelan), 1.018 (UK Biobank Cervical), and 1.008 (UK Biobank, Ovarian); the O’Mara, Phelan, 
and UK Biobank (cervical) datasets exhibited an inflation of p-values, with the Lawrenson dataset 















Figure 2: Manhattan and QQ Plots for Individual Data Sources. Data is presented for O’Mara et al., 2018 (2A and 2B), Lawrenson et al., 2019 (2C and 




3.2 Meta-Analysis Results 
3.2.1 Ovarian+Endometrial Cancer Meta-Analysis 
Abbreviated results for the Ovarian+Endometrial meta-analysis are shown in Table 1. In 
total, there were approximately 2,155 variants that were found to be significantly associated with 
the outcomes at the level of p<0.5x10-8. As such, variants were selected on the basis of being the 
‘most significant’ variant per locus, per chromosome. Heterogeneity results for selected significant 
markers is presented in Table 1. Graphical results for the overall meta-analysis are presented in 
Figure 3A and 3B. Locus plots for the most statistically significant variant per significant locus 
are presented in Figures 4A through 4H, which also include forest plots for the variant. Locus plots 
display the regional section along the chromosome for variants that were found to be highly 
significant, as well as the surrounding variants. Variants in locus plots are colored according to 
their correlation by non-random population association (linkage disequilibrium) relative to the 
highly significant variant; in the locus plots, warmer colors correspond to higher correlation, with 
the highly significant variant (or, in the case of missing linkage disequilibrium, a neighboring 
variant) represented by a purple diamond. Nearby genes characterized by the GWAS Catalog are 
shown below locus plots.  
 
Each of the top 12 variants in this meta-analysis were present in both O’Mara et al. (2018) 
and Phelan et al. (2017), and three of the 12 variants were missing from the Lawrenson et al. (2019) 
dataset (Table 1). Further, some of the effect estimates were relatively small for selected variants 
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(e.g., the lowest beta value at variant 2:177037831 corresponds to an odds ratio of approximately 
0.94), and the direction of the underlying effects for all selected variants was consistent between 
the O’Mara et al. (2018) and Phelan et al. (2017) studies, with the exception of 17:44212527 (Table 
1). Additionally, heterogeneity tests showed high heterogeneity in underlying studies, as most of 
the variants showed significant heterogeneity tests (Table 1). 
 
 Comparing the Manhattan plots for the O’Mara et al. (2018), Phelan et al. (2017), and 
Lawrenson et al. (2019) datasets (Figures 2A,2C,2E) with the O+E Manhattan plot (Figure 3A), 
the meta plot most closely resembles the Phelan data in terms of significant loci. However, both 
the Phelan et al. and O’Mara et al. datasets overlap a significant locus on chromosome 8, with the 
nearest annotated gene listed as LINC00824. The TIPARP locus on chromosome 3, on the other 
hand, appears in the Phelan et al. (2017) ovarian cancer data, but there were no significant variants 
for chromosome 3 in the O’Mara et al. (2018) endometrial cancer data. The quantile plot (Figure 
3B) exhibits a non-uniform p-value distribution, similar to both the O’Mara et al. (2018) and 
Phelan et al. (2017) quantile plots (Figures 2B and 2F), contrasting the relatively non-deviant 











Figure 4: Locus and Forest Plots for High Significant Variants in O+E. Locus and forest plots are shown for O+E variant 5:1282319 (4A and 4B), 
8:129541931 (4C and 4D), 9:13615500 (4E and 4F), and 17:29181220 (4G and 4H). For variants without linkage disequilibrium information, a neighbor 
variant with information was selected; in these cases, both variants are labeled to show the variant of interest and its neighbor. 
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Table 1: Significant Top Loci Variants for O+E Meta-Analysis 





Beta SE P-Value Direction* Het. P-Value 
2:177037831 2 177037831 C G -0.067 0.011 9.4x10-12 --- 0.00004 
3:156413477 3 156413477 T C 0.263 0.023 1.0x10-29 +?+ 6.1x10-11 
5:1282319 5 1282319 A C 0.092 0.011 3.1x10-17 +++ 0.569 
8:82653644 8 82653644 A G 0.122 0.020 2.3x10-9 +?+ 0.036 
8:129541931 8 129541931 A G -0.157 0.016 2.7x10-22 --- 0.870 
9:16889937 9 16889937 A C -0.132 0.012 1.9x10-26 --- 3.3x10-10 
9:136155000 9 136155000 T C 0.084 0.013 3.4x10-11 +++ 0.175 
10:21821274 10 21821274 A G 0.068 0.011 1.5x10-9 +-+ 0.043 
13:73814891 13 73814891 T G -0.070 0.012 4.8x10-9 -+- 5.3x10-8 
17:29181220 17 29181220 A AT -0.082 0.012 3.7x10-12 --- 0.370 
17:44212527 17 44212527 A G 0.106 0.015 7.8x10-12 -?+ 0.045 
19:17390917 19 17390917 C G -0.069 0.010 1.9x10-11 --- 0.0002 
*’Direction’ column represents sign of the effect estimate in (left to right): O’Mara et al. (2018), Lawrenson et al. (2019),  Phelan et al. (2017). The ‘?’ 
indicates a missing marker from the input study. 
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The four markers that did not demonstrate significant heterogeneity were the variants with 
significant associations in the O’Mara et al. (2018) study and one or both of the Phelan et al. (2017) 
and Lawrenson et al. (2019) studies. As such, these variants are explored here. Forest plots for 
these SNPs (Figures 4B,D,F,H) demonstrate that for the four selected significant meta effect 
estimates, the underlying Phelan et al. (2017) effect estimates were significantly associated with 
ovarian cancer in all four variants while the underlying Lawrenson et al. (2019) effect estimates 
were only found to be significantly associated with ovarian cancer in two of the variants: 
9:13615500 and 5:1282319 (Figures 4B and 4F). Similarly, the underlying O’Mara et al. (2018) 
effect estimates were found to be significantly associated with endometrial cancer in all four 
variants. Further significant variants are shown in Appendix A. Effect estimates that were 
significant across underlying individual studies were slight in magnitude, resulting in relatively 
weak meta estimates where significantly associated with either cancer outcome. Eight of the 12 
variants demonstrated significant heterogeneity, indicating these markers may not provide 
evidence of shared effects.  
 
3.2.2 Ovarian+Cervical Cancer Meta-Analysis Results 
There were five variants significantly associated with ovarian+cervical cancer at the 
threshold of p-value<5x10-8, two of which were associated with the same locus. Significant 
variants and heterogeneity test results are presented in Table 2. Graphical results for the overall 











Figure 6: Locus and Forest Plots for High Significant Variants in O+C.  Locus and forest plots are shown for O+C variants 6:66363605 (6A and 6B), 
12:31954662 (6C and 6D), 12:121056263 (6E and 6F), and 18:31370348 (6G and 6H). For variants without linkage disequilibrium information, a 






Table 2: All Significant Variants for O+C Meta-Analysis 





Beta SE P-Value Direction* 
Het. P-
Value 
6:66363605 6 66363605 A G 0.002 0.0003 3.3x10-8 +?- 0.090 
12:31954662 12 31954662 T G 0.002 0.0004 2.3x10-9 +?- 0.791 
12:120946783 12 120946783 A G 0.003 0.0005 2.5x10-8 +?- 0.687 
12:121056263 12 121056263 C G 0.003 0.0004 2.4x10-10 +?- 0.877 
18:31370348 18 31370348 A G 0.003 0.0004 1.3x10-8 +?- 0.649 
*‘Direction’ column represents sign of the effect estimate in (left to right): UK Biobank (cervical) (2018), Lawrenson et al.  (2019), Phelan et al. (2017). 
The ‘?’ indicates a missing marker from the input study. 
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The Manhattan plot (Figure 5A) shows three of the five significant variants of interest were 
located on chromosome 12. The quantile plot demonstrates that the distribution of p-values was 
fairly uniform (Figure 5B). Few of the significant variants (or their neighbor, in the case of 
12:31954662) showed linkage disequilibrium with nearby variants. All significant variants for this 
analysis showed opposite direction in underlying effects for the input data sources. Variant 
6:66363605 exhibited moderate linkage disequilibrium with a few neighbors (Figure 6A). Variant 
12:31954662 showed high linkage disequilibrium with one neighbor, as did variant 18:31370348, 
and variant 12:121056263 showed low to moderate linkage disequilibrium with several nearby 
variants (Figures 6C,E,G). Forest plots (along with Table 2) showed that effect estimates and 
standard errors for meta estimates were extremely weak, such that estimates and confidence 
intervals in forest plots overlapped by rounding. Heterogeneity tests showed low heterogeneity 
between individual studies and no tests were significant at the threshold of p<0.05 (Table 2); 
however, the direction of effect is opposite for each of the top variants. As such, there is little 
between-study heterogeneity, however, there were no top significant variants with significant 
underlying effect estimates from either the Phelan et al. (2017) or Lawrenson et al. (2019) datasets.  
3.2.3 Ovarian-Only Meta-Analysis Results 
Overall results for the ovarian-only meta-analysis are shown in the Manhattan and quantile 
plots, Figures 7A and B. Results for other top significant variants (i.e., those with only one 
underlying significant effect estimate from either the Phelan et al. (2017) or Lawrenson et al. 
(2019) datasets) are presented in Table 3. No significant results were generated with all three 
datasets included (specifically, the UK Biobank ovarian cancer dataset was absent in the 39 total 




The majority of significant SNPs were located on chromosome 17, however, there were a 
few significant SNPs in chromosomes 2, 3, 9, and 19 (Figure 7A). The quantile plot showed that 
the distribution of p-values was not uniform (Figure 7B). Comparing the Manhattan plot with that 
of the Lawrenson et al. (2019) data in Figure 2E, the cluster of significant SNPs on chromosome 
17 seems to be shared between the two; that is, the meta estimates were weighted in favor of the 
significant SNPs and less on the Lawrenson et al. (2019) data (Figure 2C). 
 
Since the underlying Lawrenson et al. (2019) effect estimates were not significant for most 
of the selected significant meta estimates (except in the case of 3:156481585, Figures 8C and 8D), 
the meta effect estimates were generally highly similar to the Phelan et al. (2017) estimates 
(Appendix A). This variant showed few other significant variants surrounding it, and there was 
low linkage disequilibrium in the region. Variants for which one underlying data source was 
significant and for which both data sources were consistent in effect direction are presented in 
Figures 8A, 8B, and 8E through 8J. Many of these variants followed a trend similar to the variant 
in Figure 8C, in that there were few other significant variants in their region, there was generally 














Figure 8: Locus and Forest Plots of the High Significant Variants for Ovarian-Only Meta-Analysis Locus and forest plots are shown for O-Only 
variants 2:176753806 (8A and 8B), 3:156481585 (8C and 8D), 9:16913836 (8E and 8F), 17:46457047 (8G and 8H), and 19:17374507 (8I and 8J). For the 
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variants without linkage disequilibrium information, a neighbor variant with information was selected; in these cases, both variants are labeled to show 











Base Allele Beta SE P-Value Direction 
Het. P-
Value 
2:176753806 2 176753806 A T 0.094 0.015 2.1x10-10 ?++ 0.053 
3:156481585 3 156481585 CAG C -0.127 0.017 2.3x10-14 ?-- 0.624 
8:129480083 8 129480083 G GT -0.113 0.020 8.5x10-9 ?+- 0.137 
9:16913836 9 16913836 A T 0.138 0.013 6.6x10-25 ?++ 0.946 





0.113 0.016 4.7x10-12 ?-+ 0.018 
17:44260644 17 44260644 A AT 0.111 0.016 2.5x10-12 ?-+ 0.151 
17:44517766 17 44517766 A T 0.120 0.018 5.5x10-11 ?-+ 0.103 
17:46457047 17 46457047 T C 0.095 0.015 3.9x10-10 ?++ 0.041 
19:17374507 19 17374507 G GCAAGAC 0.076 0.013 7.4x10-9 ?++ 0.150 
*’Direction’ column represents sign of the effect estimate in (left to right): UK Biobank (ovarian) (2018), Lawrenson et al. (2019), Phelan et al. (2017). 




The ovarian+endometrial meta-analysis overall showed the highest number of variants 
significant at p<5x10-8, and when comparing the Manhattan plots between this meta-analysis and 
its individual studies, the Phelan et al. (2017) results seem to be responsible for most of the peaks 
in the pooled results. However, both the Phelan (2017) and O’Mara (2018) show a strong peak in 
chromosome 8 (LINC00824 peak), and both show peaks in chromosome 17. At least one variant 
in the LINC00824 region has been associated with endometrial cancer, specifically, 8q24.21 
(rs4733613-C), also implicated in telomeric processes (Cheng et al., 2016). None of the underlying 
variants (Phelan, O’Mara, Lawrenson datasets) were significant for the peak at 17:29181220 
(Figures 4G, 4H), nor any of the nearby variants, yet the pooled estimates show a significant group 
of SNPs in this region. Of note, some previously studied shared genetic factors between ovarian 
and endometrial cancers were not observed in this analysis, specifically, ANXA4, UGT1A1, 
FXYD2, and GLRX identified by Zorn et al. (2005).  
 
The ovarian+endometrial meta-analysis showed several loci associated with genes that 
have been studied in relation to both ovarian and endometrial cancers. The locus with variant at 
5:1282319 (Figures 4A and 4B) was significantly associated with the outcomes across all the input 
studies, and was located on the TERT gene region, which primarily functions in regulation of 
telomere length, but has been implicated in the development of ovarian cancer (Dratwa et al., 
2020). Further, there are several SLC genes surrounding this locus, and generally, solute transport 
genes have been reported as potential tumor suppressive (Bhutia et al., 2016). Lastly, this locus 
was also close to the CLPTM1L gene, responsible for a transmembrane protein that has been 
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associated with cancers including lung, pancreas, skin, breast, ovary, and cervix (Li et al., 2020). 
Further, the TERT-CLPTM1L region has been found to host several individual variants associated 
with increased endometrial cancer risk (Carvajal-Carmona et al., 2015). 
 
The variant at 8:129541931 (Figures 4C and 4D) did not generate nearby gene hits in the 
GWAS catalog, indicating it may fall in a non-coding region. The 9:13615500 (Figures 4E and 
4F) variant showed several genes upstream and downstream of the locus, which itself was located 
on the ABO region. ABO has been correlated with both ovarian and endometrial cancers, 
specifically in women with type A blood groups (Wang-Hong et al., 2011; Gates et al., 2011). 
There were a number of surfeit genes found surrounding the locus. There is limited evidence 
suggesting SURF genes may be related in the development of cancers – specifically, one study 
found increased expression in SURF4 in tumor tissue (Kim et al., 2018). Additionally, the nearby 
GBGT1 region has been associated with ovarian cancer, but has not specifically been implicated 
in endometrial cancers (Jacob et al., 2014). Another regional gene, REXO4, exhibits exonuclease 
activity that may be related to upregulation and DNA alteration in breast cancers (Krishnamurthy 
et al., 2011). Similarly, increased expression of the CACFD1 gene, another nearby gene to this 
locus, has been linked to increased tumor growth in breast cancers (Madan et al., 2019). 
Additionally, the BNC2 gene, identified by Cesaratto et al. (2016) as a protective factor against 
ovarian cancer, was also identified in this analysis (variant 9:16889937), however, this variant was 
only significant for the underlying ovarian estimates, and not the endometrial estimate (Appendix 
A). Given the number of significant results identified in this analysis, there are a number of variants 




The variant at 17:29181220 (Figures 4G and 4H) was located in the ATAD5 region, a gene 
which has been associated with both endometrial and ovarian cancers (Kostovska et al., 2016; 
Kuchenbaecker et al., 2015). One study suggested that increased expression of TEFM, a gene close 
by this locus, was related to elevated growth and metastasis of hepatocellular carcinomas (Wan et 
al., 2021). Another nearby gene, ADAP2, was recognized in one study by weighted gene co-
expression network, to be a hub gene for acute myeloid leukemia (Yu et al., 2020). Lastly, another 
nearby gene to this locus, RNF135, was  thought to be downregulated in association with 
attenuated glioblastoma proliferation (Liu et al., 2016).  
 
Regarding overall ovarian+endometrial results, one study reported the rearrangement and 
amplification of KANSL1 (variant 17:44212527, Appendix A) in ovarian cancer, while another 
described its role more generally in tumors of the breast, prostate, lung, and in glioblastomas and 
lymphomas, though the latter study suggested the role is dependent on ancestry (positive for 
European, negative for Asian and African) (Fejzo et al., 2021; Zhou et al., 2017). SKAP1 (variant 
17:44212527, Appendix A) has been implicated in both ovarian and breast cancers, which has 
been thought to function in the regulation of T-cells, though could potentially affect tumorigenesis 
regardless of cell-type (Marcotte et al., 2012). Some genes near the 19:17390917 locus (Appendix 
A) have been studied in relation to gynecologic cancers, specifically, ANKLE1 and ABHD8 have 
both been associated with ovarian cancer, and MRPL34 with breast cancer. Increased expression 
of ABHD8 was found to be associated with reduced breast and ovarian cancer cell activity, while 
ANKLE1 demonstrated increased growth and proliferation of both breast and ovarian cancer cells 
with increased expression (Lawrenson et al., 2016). MRPL34 was found to have an association 
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with higher risk and lower survival rate in breast cancer when it was recorded at lower expression 
levels (Baxter et al., 2018).  
 
The ovarian+cervical meta-analysis was overall unsuccessful at identifying compelling 
significant variants. That is, the few significant variants were only significant for one underlying 
dataset. Further, these variants were ‘localized’, in that they did not show other significant variants 
in their vicinity. As such, it is difficult to conclude shared genetic factors from this specific 
analysis. It is possible that cervical cancers share fewer genetic factors with ovarian cancers than 
endometrial cancers, for example, as it is predominantly related to HPV (with minor relation to 
Peutz-Jeghers syndrome), while the other gynecologic cancers may have a greater number of risk 
factors (Ledford and Lockwood, 2019; Constantinou and Tischkowitz, 2017).  
 
Regarding overall results for the ovarian+cervical meta-analysis, the EYS gene (variant 
6:66363605, Figures 6A and 6B) has not been widely implicated in association with cancers. The 
RNU6-1069P (variant 12:31954662, Figures 6C and 6D) and AC125616.1 (variant 12:121056263, 
Figures 6E and 6F) genes have also not been studied in relation to tumors of gynecologic or other 
origin. The ASXL3 gene (variant 18:31370348, Figures 6G and 6H), on the other hand, has been 
assessed for its role in respiratory cancer in humans in one study which found its high expression 
to be associated with increased copy number in cancer cells, as well as that it targeted and inhibited 
malignant growth (Shukla et al., 2017). Therefore, these may provide opportunities for follow-up 
assessment to determine any potential relationship between these variants and either ovarian and/or 




Results from the ovarian-only meta-analysis were somewhat mixed. Most of the highly 
significant variants per locus were only significant in the underlying Phelan et al. (2017) data, and 
none of the significant variants were present in the filtered ovarian cancer UK Biobank (2018) 
data. This is most likely the result of combining genotyped data from different arrays. That is, the 
UK Biobank incorporated data genotyped on an array purposed for a wide variety of endpoints, 
where the other three data sources used cancer-specific genotyping arrays (Bycroft et al., 2018; 
Phelan et al., 2017; Lawrenson et al., 2019; O’mara et al., 2018). As such, some alleles may have 
been coded differently for the same variants across platforms.  
 
The LNPK gene has not been consistently associated with ovarian cancer (variant 
2:176753806, Figures 8A and 8B). While AL162725.2 (variant 9:16913836, Figure 8E) has not 
been thoroughly studied in relation with cancers, there are other variants that are significant nearby 
on chromosome 9 that overlap BNC2 (Figure 8E). BNC2 has been associated as a protective gene 
against ovarian cancer (Cesaratto et al., 2016). KANSL1 and SKAP1 (chromosome 17 variants, 
Appendix A and Figures 8G and 8H) have, as well, been implicated in ovarian cancer (Fejzo et 
al., 2021; Zhou et al., 2017; Marcotte et al., 2012). Further, the variant at 19:17374507 (Figure 8I) 
was very close to the genes ABHD8, ANKLE1, and MRPL34, which were identified as ovarian 
cancer factors in the ovarian+endometrial analysis. Pan et al. (2018) examined the role of MAPT-
AS1 (chromosome 17 variants, Appendix A) in relation to breast cancer cells, and found that it was 
correlated negatively with tumor cell growth and expansion, and theorized that its overexpression 




The variant at 3:156481585 did not show linkage disequilibrium with its neighbor variants 
(Figure 8C). Heterogeneity tests for the remaining variants were largely not significant (Table 3). 
The heterogeneity test for this variant was not significant, indicating little heterogeneity between 
the Lawrenson et al. (2019) and Phelan et al. (2017) studies for this variant. The selected variant 
did not appear to be associated with a specific gene region (Figure 8C). However, it had a 
significant neighbor variant that was associated with the TIPARP gene. This gene has been 
associated with both breast cancer as well as ovarian cancer, with reduced expression being 
associated with greater ovarian tumor development (Cheng et al., 2019; Goode et al., 2010). 
Permuth et al. (2016) demonstrated that another nearby gene region, LEKR1, was associated with 
epithelial ovarian cancer. Additionally, Ramakrishna et al. (2010) demonstrated that KCNAB1, 
TIPARP, and SSR3, close genes to this locus, were associated with promoted growth of ovarian 
cancer cells by increased expression. 
 
The ovarian-only meta-analysis showed some significant genes that were also identified 
by the ovarian+endometrial meta-analysis, chiefly, BNC2, KANSL1 and SKAP1, all of which have 
been found to be associated in some manner with ovarian cancers (Cesaratto et al., 2016; Fejzo et 
al., 2021; Zhou et al., 2017; Marcotte et al., 2012). This analysis additionally identified the 
TIPARP, ABHD8, ANKLE1, and MRPL34 genes, also found in the ovarian+endometrial analysis. 
As such, these findings may underscore the importance of these genes in ovarian cancers, with 
potential importance to endometrial cancer.  
 
The majority of genes that were found to be significant in these analyses that were 
associated with a gynecologic cancer were associated with ovarian cancer, specifically. This might 
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be logical given that ovarian cancer datasets were included in all analyses. However, this does not 
necessarily indicate that those genes found related to ovarian cancer are only related to ovarian 
cancer. Those genes may be associated with ovarian or the other gynecologic cancer involved in 
the model, respectively. Further, some of the genes that have not been documented in association 
with any cancer, may truly be associated with one or more of the gynecologic cancer sub-types.  
There were variants in gene groups identified in this analysis that may be influential for more than 
one gynecologic cancer sub-type, particularly those that have not been heavily researched in 
connection with gynecologic cancers like the SLC and SURF gene groups. These potential factors 
supplement previous findings of shared genetic variants, like those reported on by Wang et al. 
(2018) (e.g., MCM2, MMP2, COLIA1, JUN). As such, these results may add to the existing 
evidence that gynecologic cancers share some genetic variants and gene groups. 
4.1 Limitations 
There are several limitations that are imperative to discuss relative to these analyses. 
Primarily, there were very few datasets to incorporate. This can lead to some individual results 
exerting high influence over the pooled estimates, which occurred in some of these analyses. That 
is, results are not very informative if they are driven primarily by one input dataset, with missing 
variants in other datasets. This was particularly the case evident in the ovarian+cervical cancer 
dataset, where few significant results were seen, and those that were significant were not able to 
be assessed in the Lawrenson et al. (2019) data. For these significant variants, the minor allele 
frequencies in Asian ancestry individuals is small and would not have been included at the level 
of minor allele frequency greater than 0.01. While there was data from the UK Biobank cervical 
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cancer dataset present in the five significant variants, there was no data assessed in the significant 
results from the UK Biobank in the ovarian-only analysis, perhaps due to genotyping performed 
on different arrays, limiting power and generalizability of these results.  
 
Further, there were no vaginal cancer or vulvar cancer datasets, and due to some sample 
overlap, each analysis contained the same two ovarian cancer datasets; therefore, there is little to 
conclude about the breadth of gynecologic cancer outcomes.  
 
Heterogeneity was also an issue for these analyses. Some variants that were found 
significant in the models showed significant heterogeneity tests, indicating that those variants are 
not good representations of true shared genetic architecture. In a broader sense, the liberties taken 
with the homogeneity assumption of meta-analysis means that variants can only be suggested for 
effect, and that no conclusions can be drawn about the magnitude of association for any of the 
cancer outcomes (with the exception of the ovarian-only meta-analysis). Further, combining 
datasets across ethnicity groups may impact the combinability of some variants, since ancestry 
greatly influences allelic frequencies and common polymorphisms. Since the Lawrenson et al. 
(2019) data was performed on individuals of Asian ancestry, this may explain some of the 
missingness in significant results (specifically, in the ovarian+cervical analysis), as well as the 
generalizability of results, as causal variants and genetic risk factors may not be consistent across 
ancestry groups. The strengths and weaknesses of applying the fixed effects paradigm to a cross-
trait analysis are discussed in Section 2.2. In essence, the trade-off of discovering as many 
potentially shared variants as possible (increasing statistical power by using fixed effects) is 




Additionally, because only summary results were available, no other verifications of 
underlying genotyping data or follow-up analyses were possible. Further, since per-SNP sample 
sizes were not included for the majority of datasets, a sample-weighted analysis was not possible. 
Lastly, sample size imbalances were observed across the studies. Specifically, the Phelan et al. 
(2017) dataset provided approximately 25,000 cases, whereas the UK Biobank dataset reported 
only having less than 1,000 cases in both the ovarian and cervical datasets. As such, some of the 
results were likely dominated by the larger datasets, that is, the results may be biased toward the 
larger datasets.  
4.2 Conclusion 
In conclusion, these analyses summarized pooled estimates across combinations of ovarian 
cancer datasets with one endometrial and one cervical cancer dataset. Existing shared effects were 
verified in the ovarian+endometrial analysis specifically, including TERT, CLPTM1L and ATAD5. 
Several variants were identified that are well-characterized in terms of ovarian cancer association, 
but warrant further investigation in potential association with the other cancer outcomes. Examples 
include, for endometrial cancer, SLC genes, SURF genes, ABO, and BNC2, and for cervical cancer, 
EYS, RNU6-1069P, AC125616.1, and ASXL3 are genes that may warrant further investigation into 
potential roles in the genesis and growth of these conditions. 
 
As such, one future research direction may include investigating the nearest genes found 
to the highly significant variants that were not already documented in association with a 
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Figure 9: Locus and Forest Plots for Other Highly Significant Variants in the O+E and O-Only Meta-
Analyses. Locus and forest plots are shown for O+E variants 2:177037831 (9A and 9B), 3:156413477 (9C and 
9D), 8:82653644 (9E and 9F), 9:16889937 (9G and 9H), 10:21821274 (9I and 9J), 13:73814891 (9K and 9L), 
17:44212527 (9M and 9N), 19:17390917 (9O and 9P), and O-Only variants 8:129480083 (9Q and 9R), 
17:43956139 (9S and 9T), 17:44260644 (9U and 9V), and 17:44517766 (9W and 9X). For the variants without 
linkage disequilibrium information, a neighbor variant with information was selected; in these cases, both 
variants are labeled to show the variant of interest and its neighbor. 
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#Dataframes with combined results in one file: 
 
#Cervical Cancer: 
ukbb <- as.data.frame(fread("C53.gwas.imputed_v3.female.tsv")) 
 
#ukbbcont <- as.data.frame(fread("ukbbcont.tsv")) 
#^^^ C53 has 192 cases and 193982 controls. 
#^^^ C56 has 691 cases and 193483 controls. 
 
#Endometrial Cancer: 
omara <- as.data.frame(fread("harmonised.qc.tsv")) 
 
omara_bed <- omara[,c(15,14,13)] 
omara_bed <- arrange(omara_bed, omara_bed$chromosome, omara_bed$base_pair_location) 
omara_bed$chromStart <- omara_bed$base_pair_location - 1 
omara_bed$chromEnd <- omara_bed$base_pair_location 
omara_bed <- omara_bed[,c(1,4,5,3)] 
omara_bed$chromosome <- paste("chr", omara_bed$chromosome, sep="") 
#write.table(omara_bed, sep="\t",file="C:\\Users\\Mark\\Documents\\omara_bed.txt", row.names = FALSE, col.names 
= FALSE, quote = FALSE) 
omara_liftover <- read.table("hglft_results.txt", sep="\t") 
 
omara_liftover <- omara_liftover %>% rename(base_pair_location=V3, variant_id=V4) 
 
omara_merge <- merge(omara, omara_liftover[,c(3,4)], by="variant_id") 
 





omara$chrpos <- paste(omara$chromosome, omara$base_pair_location.y, sep=":") 
omara <- omara %>% rename(base_pair_location=base_pair_location.y) 
#Mapping UKBB rsIDs: 
ukvariants <- as.data.frame(fread("variants.tsv")) 
ukvariants$chrpos <- paste(ukvariants$chr, ukvariants$pos, sep=":") 





#Filter MAF < 0.01, nonsense p-val,se: 
ukbb <- ukbb %>% filter(minor_AF > 0.01) %>% filter(se > 0) %>%  
                  filter(pval < 1 & pval > 0) 
#```{r, include=FALSE} #Creating pre-test dataframes for the studies: 
 
law1 <- read.table(“SummaryResults_Asian_chr1.txt”, header=TRUE,sep=“,”) law2 <- 
read.table(“SummaryResults_Asian_chr2.txt”, header=TRUE,sep=“,”) law3 <- read.table(“SummaryResults_Asian_chr3.txt”, 
header=TRUE,sep=“,”) law4 <- read.table(“SummaryResults_Asian_chr4.txt”, header=TRUE,sep=“,”) law5 <- 
read.table(“SummaryResults_Asian_chr5.txt”, header=TRUE,sep=“,”) law6 <- read.table(“SummaryResults_Asian_chr6.txt”, 
header=TRUE,sep=“,”) law7 <- read.table(“SummaryResults_Asian_chr7.txt”, header=TRUE,sep=“,”) law8 <- 
read.table(“SummaryResults_Asian_chr8.txt”, header=TRUE,sep=“,”) law9 <- read.table(“SummaryResults_Asian_chr9.txt”, 
header=TRUE,sep=“,”) law10 <- read.table(“SummaryResults_Asian_chr10.txt”, header=TRUE,sep=“,”) law11 <- 
read.table(“SummaryResults_Asian_chr11.txt”, header=TRUE,sep=“,”) law12 <- read.table(“SummaryResults_Asian_chr12.txt”, 
header=TRUE,sep=“,”) law13 <- read.table(“SummaryResults_Asian_chr13.txt”, header=TRUE,sep=“,”) law14 <- 
read.table(“SummaryResults_Asian_chr14.txt”, header=TRUE,sep=“,”) law15 <- read.table(“SummaryResults_Asian_chr15.txt”, 
header=TRUE,sep=“,”) law16 <- read.table(“SummaryResults_Asian_chr16.txt”, header=TRUE,sep=“,”) law17 <- 
read.table(“SummaryResults_Asian_chr17.txt”, header=TRUE,sep=“,”) law18 <- read.table(“SummaryResults_Asian_chr18.txt”, 
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header=TRUE,sep=“,”) law19 <- read.table(“SummaryResults_Asian_chr19.txt”, header=TRUE,sep=“,”) law20 <- 
read.table(“SummaryResults_Asian_chr20.txt”, header=TRUE,sep=“,”) law21 <- read.table(“SummaryResults_Asian_chr21.txt”, 
header=TRUE,sep=“,”) law22 <- read.table(“SummaryResults_Asian_chr22.txt”, header=TRUE,sep=“,”) law23 <- 
read.table(“SummaryResults_Asian_chr23.txt”, header=TRUE,sep=“,”) law <- 
rbind(law1,law2,law3,law4,law5,law6,law7,law8,law9,law10,law11,law12, 
law13,law14,law15,law16,law17,law18,law19,law20,law21,law22,law23) lawchrpos<−paste(lawChromosome, law$Position, 
sep=“:”) law <- law %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% filter(overall_pvalue > 0 & 
overall_pvalue < 1) law <- law[,c(1:12,41)] 
 
write.table(law, sep=“,file=”C:\Users\Mark\Documents\law_pretest.txt", row.names = FALSE, col.names = TRUE, 
quote = FALSE) rm(law) rm(list = c(‘law1’,‘law2’,‘law3’,‘law4’,‘law5’,‘law6’,‘law7’,‘law8’,‘law9’, 
‘law10’,‘law11’,‘law12’,‘law13’,‘law14’,‘law15’,‘law16’,‘law17’, ‘law18’,‘law19’,‘law20’,‘law21’,‘law22’,‘law23’)) 
 
phe1 <- read.table(“Summary_chr1.txt”, header=TRUE, sep=“) phe2 <- read.table(”Summary_chr2.txt“, header=TRUE, 
sep=”,“) phe3 <- read.table(”Summary_chr3.txt“, header=TRUE, sep=”,“) phe4 <- read.table(”Summary_chr4.txt“, header=TRUE, 
sep=”,“) phe5 <- read.table(”Summary_chr5.txt“, header=TRUE, sep=”,“) phe6 <- read.table(”Summary_chr6.txt“, header=TRUE, 
sep=”,“) phe7 <- read.table(”Summary_chr7.txt“, header=TRUE, sep=”) phe8 <- read.table(“Summary_chr8.txt”, header=TRUE, 
sep=“,”) phe9 <- read.table(“Summary_chr9.txt”, header=TRUE, sep=“,”) phe10 <- read.table(“Summary_chr10.txt”, 
header=TRUE, sep=“,”) phe11 <- read.table(“Summary_chr11.txt”, header=TRUE, sep=“,”) phe12 <- 
read.table(“Summary_chr12.txt”, header=TRUE, sep=“,”) phe13 <- read.table(“Summary_chr13.txt”, header=TRUE, sep=“,”) 
phe14 <- read.table(“Summary_chr14.txt”, header=TRUE, sep=“,”) phe15 <- read.table(“Summary_chr15.txt”, header=TRUE, 
sep=“,”) phe16 <- read.table(“Summary_chr16.txt”, header=TRUE, sep=“,”) phe17 <- read.table(“Summary_chr17.txt”, 
header=TRUE, sep=“,”) phe18 <- read.table(“Summary_chr18.txt”, header=TRUE, sep=“,”) phe19 <- 
read.table(“Summary_chr19.txt”, header=TRUE, sep=“,”) phe20 <- read.table(“Summary_chr20.txt”, header=TRUE, sep=“,”) 
phe21 <- read.table(“Summary_chr21.txt”, header=TRUE, sep=“,”) phe22 <- read.table(“Summary_chr22.txt”, header=TRUE, 
sep=“,”) phe23 <- read.table(“Summary_chr23.txt”, header=TRUE, sep=“,”) 
 
#Subsetting first because overall vector is too big: phe1 <- phe1[,c(1:12)] phe2 <- phe2[,c(1:12)] phe3 <- phe3[,c(1:12)] 
phe4 <- phe4[,c(1:12)] phe5 <- phe5[,c(1:12)] phe6 <- phe6[,c(1:12)] phe7 <- phe7[,c(1:12)] phe8 <- phe8[,c(1:12)] phe9 <- 
phe9[,c(1:12)] phe10 <- phe10[,c(1:12)] phe11 <- phe11[,c(1:12)] phe12 <- phe12[,c(1:12)] phe13 <- phe13[,c(1:12)] phe14 <- 
phe14[,c(1:12)] phe15 <- phe15[,c(1:12)] phe16 <- phe16[,c(1:12)] phe17 <- phe17[,c(1:12)] phe18 <- phe18[,c(1:12)] phe19 <- 
phe19[,c(1:12)] phe20 <- phe20[,c(1:12)] phe21 <- phe21[,c(1:12)] phe22 <- phe22[,c(1:12)] phe23 <- phe23[,c(1:12)] 
 
phe <- rbind(phe1,phe2,phe3,phe4,phe5,phe6,phe7,phe8,phe9,phe10,phe11,phe12, 
phe13,phe14,phe15,phe16,phe17,phe18,phe19,phe20,phe21,phe22,phe23) phechrpos<−paste(pheChromosome, phe$Position, 
sep=“:”) phe <- phe %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% filter(overall_pvalue > 0 & 
overall_pvalue < 1) 
 
phe <- arrange(phe, Chromosome, Position) 
 
write.table(phe, sep=“,file=”C:\Users\Mark\Documents\phe_pretest.txt", row.names = FALSE, col.names = TRUE, 





#Create and format pre-test dataframes for OMARA & UKBB: 
 
omara <- omara %>% filter(effect_allele_frequency > 0.01 & effect_allele_frequency < 0.99) %>% filter(standard_error 
> 0) %>% 
                  filter(p_value > 0 & p_value < 1) 
omara <- arrange(omara, chromosome, base_pair_location) 
 
#write.table(omara, sep="\t", file="C:\\Users\\Mark\\Documents\\omara_pretest.txt", row.names=FALSE, col.names = 
TRUE, quote = FALSE) 
 
ukbb <- arrange(ukbb, chr, pos) 
 
#write.table(ukbb, sep="\t", file="C:\\Users\\Mark\\Documents\\ukbb_pretest.txt", row.names = FALSE, col.names = 






omara_1 <- omara %>% filter(chromosome == 1) 
phelan_1 <- read.table("Summary_chr1.txt", header=TRUE, sep="\t") 
lawrenson_1 <- read.table("SummaryResults_Asian_chr1.txt", header=TRUE, sep=",") 
ukbb_1 <- filter(ukbb, grepl("^1:", chrpos)) 
#Clean SNP naming convention - chr:pos 
 
phelan_1$chrpos <- paste(phelan_1$Chromosome, phelan_1$Position, sep=":") 
lawrenson_1$chrpos <- paste(lawrenson_1$Chromosome, lawrenson_1$Position, sep=":") 
 
 
#Prune NA entries 
 
omara_1 <- filter(omara_1, !grepl("NA", chrpos)) 
phelan_1 <- filter(phelan_1, !grepl("NA", chrpos)) 
lawrenson_1 <- filter(lawrenson_1, !grepl("NA", chrpos)) 
ukbb_1 <- filter(ukbb_1, !grepl("NA", chrpos)) 
 
phelan_1 <- phelan_1 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_1 <- lawrenson_1 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
#Organize files for analysis: 
 
omara_1 <- omara_1[,c(26,17,18,19,20,21)] 
#^ SNP,  other allele & effect allele, beta, SE, p-val. 
 
lawrenson_1 <- lawrenson_1[,c(41,6,5,9,10,12)] 
#^ SNP, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_1 <- phelan_1[,c(73,6,5,9,10,12)] 
#^ SNP, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_1 <- ukbb_1[,c(16,17,18,9,10,12)] 
#^ SNP, baseline allele, effect allele, beta, SE, overall p-val. 
#Export files for METAL format: 
 
write.table(omara_1, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr1\\omara_1.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_1, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr1\\lawrenson_1.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_1, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr1\\phelan_1.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_1, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr1\\ukbb_1.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_1','lawrenson_1','phelan_1','ukbb_1')) 
#2: 
omara_2 <- omara %>% filter(chromosome == 2) 
phelan_2 <- read.table("Summary_chr2.txt", header=TRUE, sep=",") 
lawrenson_2 <- read.table("SummaryResults_Asian_chr2.txt", header=TRUE, sep=",") 
ukbb_2 <- filter(ukbb, grepl("^2:", chrpos)) 
phelan_2$chrpos <- paste(phelan_2$Chromosome, phelan_2$Position, sep=":") 
lawrenson_2$chrpos <- paste(lawrenson_2$Chromosome, lawrenson_2$Position, sep=":") 
 
omara_2 <- filter(omara_2, !grepl("NA", chrpos)) 
phelan_2 <- filter(phelan_2, !grepl("NA", chrpos)) 
lawrenson_2 <- filter(lawrenson_2, !grepl("NA", chrpos)) 




phelan_2 <- phelan_2 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_2 <- lawrenson_2 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_2 <- omara_2[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_2 <- lawrenson_2[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_2 <- phelan_2[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_2 <- ukbb_2[,c(16,17,18,9,10,12)] 
#^ SNP, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_2, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr2\\omara_2.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_2, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr2\\lawrenson_2.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_2, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr2\\phelan_2.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_2, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr2\\ukbb_2.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_2','lawrenson_2','phelan_2','ukbb_2')) 
#3: 
omara_3 <- omara %>% filter(chromosome == 3) 
phelan_3 <- read.table("Summary_chr3.txt", header=TRUE, sep=",") 
lawrenson_3 <- read.table("SummaryResults_Asian_chr3.txt", header=TRUE, sep=",") 
ukbb_3 <- filter(ukbb, grepl("^3:", chrpos)) 
phelan_3$chrpos <- paste(phelan_3$Chromosome, phelan_3$Position, sep=":") 
lawrenson_3$chrpos <- paste(lawrenson_3$Chromosome, lawrenson_3$Position, sep=":") 
 
omara_3 <- filter(omara_3, !grepl("NA", chrpos)) 
phelan_3 <- filter(phelan_3, !grepl("NA", chrpos)) 
lawrenson_3 <- filter(lawrenson_3, !grepl("NA", chrpos)) 
ukbb_3 <- filter(ukbb_3, !grepl("NA", chrpos)) 
 
phelan_3 <- phelan_3 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_3 <- lawrenson_3 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_3 <- omara_3[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_3 <- lawrenson_3[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_3 <- phelan_3[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_3 <- ukbb_3[,c(16,17,18,9,10,12)] 
#^ SNP, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_3, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr3\\omara_3.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_3, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr3\\lawrenson_3.txt", 




write.table(phelan_3, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr3\\phelan_3.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_3, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr3\\ukbb_3.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_3','lawrenson_3','phelan_3','ukbb_3')) 
#4: 
omara_4 <- omara %>% filter(chromosome == 4) 
phelan_4 <- read.table("Summary_chr4.txt", header=TRUE, sep=",") 
lawrenson_4 <- read.table("SummaryResults_Asian_chr4.txt", header=TRUE, sep=",") 
ukbb_4 <- filter(ukbb, grepl("^4:", chrpos)) 
phelan_4$chrpos <- paste(phelan_4$Chromosome, phelan_4$Position, sep=":") 
lawrenson_4$chrpos <- paste(lawrenson_4$Chromosome, lawrenson_4$Position, sep=":") 
 
omara_4 <- filter(omara_4, !grepl("NA", chrpos)) 
phelan_4 <- filter(phelan_4, !grepl("NA", chrpos)) 
lawrenson_4 <- filter(lawrenson_4, !grepl("NA", chrpos)) 
ukbb_4 <- filter(ukbb_4, !grepl("NA", chrpos)) 
 
phelan_4 <- phelan_4 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_4 <- lawrenson_4 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_4 <- omara_4[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_4 <- lawrenson_4[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_4 <- phelan_4[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_4 <- ukbb_4[,c(16,17,18,9,10,12)] 
#^ SNP, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_4, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr4\\omara_4.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_4, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr4\\lawrenson_4.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_4, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr4\\phelan_4.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_4, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr4\\ukbb_4.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_4','lawrenson_4','phelan_4','ukbb_4')) 
#5: 
omara_5 <- omara %>% filter(chromosome == 5) 
phelan_5 <- read.table("Summary_chr5.txt", header=TRUE, sep=",") 
lawrenson_5 <- read.table("SummaryResults_Asian_chr5.txt", header=TRUE, sep=",") 
ukbb_5 <- filter(ukbb, grepl("^5:", chrpos)) 
phelan_5$chrpos <- paste(phelan_5$Chromosome, phelan_5$Position, sep=":") 
lawrenson_5$chrpos <- paste(lawrenson_5$Chromosome, lawrenson_5$Position, sep=":") 
 
omara_5 <- filter(omara_5, !grepl("NA", chrpos)) 
phelan_5 <- filter(phelan_5, !grepl("NA", chrpos)) 
lawrenson_5 <- filter(lawrenson_5, !grepl("NA", chrpos)) 




phelan_5 <- phelan_5 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_5 <- lawrenson_5 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_5 <- omara_5[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_5 <- lawrenson_5[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_5 <- phelan_5[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_5 <- ukbb_5[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_5, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr5\\omara_5.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_5, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr5\\lawrenson_5.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_5, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr5\\phelan_5.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_5, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr5\\ukbb_5.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_5','lawrenson_5','phelan_5','ukbb_5')) 
#6: 
omara_6 <- omara %>% filter(chromosome == 6) 
phelan_6 <- read.table("Summary_chr6.txt", header=TRUE, sep=",") 
lawrenson_6 <- read.table("SummaryResults_Asian_chr6.txt", header=TRUE, sep=",") 
ukbb_6 <- filter(ukbb, grepl("^6:", chrpos)) 
phelan_6$chrpos <- paste(phelan_6$Chromosome, phelan_6$Position, sep=":") 
lawrenson_6$chrpos <- paste(lawrenson_6$Chromosome, lawrenson_6$Position, sep=":") 
 
omara_6 <- filter(omara_6, !grepl("NA", chrpos)) 
phelan_6 <- filter(phelan_6, !grepl("NA", chrpos)) 
lawrenson_6 <- filter(lawrenson_6, !grepl("NA", chrpos)) 
ukbb_6 <- filter(ukbb_6, !grepl("NA", chrpos)) 
 
phelan_6 <- phelan_6 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_6 <- lawrenson_6 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_6 <- omara_6[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_6 <- lawrenson_6[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_6 <- phelan_6[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_6 <- ukbb_6[,c(16,17,18,9,10,12)] 
#^ SNP, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_6, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr6\\omara_6.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_6, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr6\\lawrenson_6.txt", 




write.table(phelan_6, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr6\\phelan_6.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_6, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr6\\ukbb_6.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_6','lawrenson_6','phelan_6','ukbb_6')) 
#7: 
omara_7 <- omara %>% filter(chromosome == 7) 
phelan_7 <- read.table("Summary_chr7.txt", header=TRUE, sep="\t") 
lawrenson_7 <- read.table("SummaryResults_Asian_chr7.txt", header=TRUE, sep=",") 
ukbb_7 <- filter(ukbb, grepl("^7:", chrpos)) 
phelan_7$chrpos <- paste(phelan_7$Chromosome, phelan_7$Position, sep=":") 
lawrenson_7$chrpos <- paste(lawrenson_7$Chromosome, lawrenson_7$Position, sep=":") 
 
omara_7 <- filter(omara_7, !grepl("NA", chrpos)) 
phelan_7 <- filter(phelan_7, !grepl("NA", chrpos)) 
lawrenson_7 <- filter(lawrenson_7, !grepl("NA", chrpos)) 
ukbb_7 <- filter(ukbb_7, !grepl("NA", chrpos)) 
 
phelan_7 <- phelan_7 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_7 <- lawrenson_7 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_7 <- omara_7[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_7 <- lawrenson_7[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_7 <- phelan_7[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_7 <- ukbb_7[,c(16,17,18,9,10,12)] 
#^ SNP, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_7, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr7\\omara_7.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_7, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr7\\lawrenson_7.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_7, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr7\\phelan_7.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_7, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr7\\ukbb_7.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_7','lawrenson_7','phelan_7','ukbb_7')) 
#8: 
omara_8 <- omara %>% filter(chromosome == 8) 
phelan_8 <- read.table("Summary_chr8.txt", header=TRUE, sep=",") 
lawrenson_8 <- read.table("SummaryResults_Asian_chr8.txt", header=TRUE, sep=",") 
ukbb_8 <- filter(ukbb, grepl("^8:", chrpos)) 
phelan_8$chrpos <- paste(phelan_8$Chromosome, phelan_8$Position, sep=":") 
lawrenson_8$chrpos <- paste(lawrenson_8$Chromosome, lawrenson_8$Position, sep=":") 
 
omara_8 <- filter(omara_8, !grepl("NA", chrpos)) 
phelan_8 <- filter(phelan_8, !grepl("NA", chrpos)) 
lawrenson_8 <- filter(lawrenson_8, !grepl("NA", chrpos)) 
ukbb_8 <- filter(ukbb_8, !grepl("NA", chrpos)) 
 
phelan_8 <- phelan_8 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
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                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_8 <- lawrenson_8 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_8 <- omara_8[,c(26,17,18,19,20,21)] 
#^ SNP, rs, harmonised other allele & effect allele, beta, SE, p-val. 
 
lawrenson_8 <- lawrenson_8[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_8 <- phelan_8[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_8 <- ukbb_8[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_8, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr8\\omara_8.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_8, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr8\\lawrenson_8.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_8, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr8\\phelan_8.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_8, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr8\\ukbb_8.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_8','lawrenson_8','phelan_8','ukbb_8')) 
#9: 
omara_9 <- omara %>% filter(chromosome == 9) 
phelan_9 <- read.table("Summary_chr9.txt", header=TRUE, sep=",") 
lawrenson_9 <- read.table("SummaryResults_Asian_chr9.txt", header=TRUE, sep=",") 
ukbb_9 <- filter(ukbb, grepl("^9:", chrpos)) 
phelan_9$chrpos <- paste(phelan_9$Chromosome, phelan_9$Position, sep=":") 
lawrenson_9$chrpos <- paste(lawrenson_9$Chromosome, lawrenson_9$Position, sep=":") 
 
omara_9 <- filter(omara_9, !grepl("NA", chrpos)) 
phelan_9 <- filter(phelan_9, !grepl("NA", chrpos)) 
lawrenson_9 <- filter(lawrenson_9, !grepl("NA", chrpos)) 
ukbb_9 <- filter(ukbb_9, !grepl("NA", chrpos)) 
 
phelan_9 <- phelan_9 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_9 <- lawrenson_9 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_9 <- omara_9[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_9 <- lawrenson_9[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_9 <- phelan_9[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_9 <- ukbb_9[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_9, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr9\\omara_9.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_9, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr9\\lawrenson_9.txt", 




write.table(phelan_9, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr9\\phelan_9.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_9, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr9\\ukbb_9.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_9','lawrenson_9','phelan_9','ukbb_9')) 
#10: 
omara_10 <- omara %>% filter(chromosome == 10) 
phelan_10 <- read.table("Summary_chr10.txt", header=TRUE, sep=",") 
lawrenson_10 <- read.table("SummaryResults_Asian_chr10.txt", header=TRUE, sep=",") 
ukbb_10 <- filter(ukbb, grepl("^10:", chrpos)) 
phelan_10$chrpos <- paste(phelan_10$Chromosome, phelan_10$Position, sep=":") 
lawrenson_10$chrpos <- paste(lawrenson_10$Chromosome, lawrenson_10$Position, sep=":") 
 
omara_10 <- filter(omara_10, !grepl("NA", chrpos)) 
phelan_10 <- filter(phelan_10, !grepl("NA", chrpos)) 
lawrenson_10 <- filter(lawrenson_10, !grepl("NA", chrpos)) 
ukbb_10 <- filter(ukbb_10, !grepl("NA", chrpos)) 
 
phelan_10 <- phelan_10 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_10 <- lawrenson_10 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_10 <- omara_10[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_10 <- lawrenson_10[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_10 <- phelan_10[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_10 <- ukbb_10[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_10, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr10\\omara_10.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_10, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr10\\lawrenson_10.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_10, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr10\\phelan_10.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_10, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr10\\ukbb_10.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_10','lawrenson_10','phelan_10','ukbb_10')) 
#11: 
omara_11 <- omara %>% filter(chromosome == 11) 
phelan_11 <- read.table("Summary_chr11.txt", header=TRUE, sep=",") 
lawrenson_11 <- read.table("SummaryResults_Asian_chr11.txt", header=TRUE, sep=",") 
ukbb_11 <- filter(ukbb, grepl("^11:", chrpos)) 
phelan_11$chrpos <- paste(phelan_11$Chromosome, phelan_11$Position, sep=":") 
lawrenson_11$chrpos <- paste(lawrenson_11$Chromosome, lawrenson_11$Position, sep=":") 
 
omara_11 <- filter(omara_11, !grepl("NA", chrpos)) 
phelan_11 <- filter(phelan_11, !grepl("NA", chrpos)) 
lawrenson_11 <- filter(lawrenson_11, !grepl("NA", chrpos)) 
ukbb_11 <- filter(ukbb_11, !grepl("NA", chrpos)) 
 
phelan_11 <- phelan_11 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
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                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_11 <- lawrenson_11 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_11 <- omara_11[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_11 <- lawrenson_11[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_11 <- phelan_11[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_11 <- ukbb_11[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_11, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr11\\omara_11.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_11, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr11\\lawrenson_11.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_11, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr11\\phelan_11.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_11, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr11\\ukbb_11.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_11','lawrenson_11','phelan_11','ukbb_11')) 
#12: 
omara_12 <- omara %>% filter(chromosome == 12) 
phelan_12 <- read.table("Summary_chr12.txt", header=TRUE, sep=",") 
lawrenson_12 <- read.table("SummaryResults_Asian_chr12.txt", header=TRUE, sep=",") 
ukbb_12 <- filter(ukbb, grepl("^12:", chrpos)) 
phelan_12$chrpos <- paste(phelan_12$Chromosome, phelan_12$Position, sep=":") 
lawrenson_12$chrpos <- paste(lawrenson_12$Chromosome, lawrenson_12$Position, sep=":") 
 
omara_12 <- filter(omara_12, !grepl("NA", chrpos)) 
phelan_12 <- filter(phelan_12, !grepl("NA", chrpos)) 
lawrenson_12 <- filter(lawrenson_12, !grepl("NA", chrpos)) 
ukbb_12 <- filter(ukbb_12, !grepl("NA", chrpos)) 
 
phelan_12 <- phelan_12 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_12 <- lawrenson_12 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_12 <- omara_12[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_12 <- lawrenson_12[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_12 <- phelan_12[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_12 <- ukbb_12[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_12, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr12\\omara_12.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_12, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr12\\lawrenson_12.txt", 




write.table(phelan_12, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr12\\phelan_12.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_12, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr12\\ukbb_12.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_12','lawrenson_12','phelan_12','ukbb_12')) 
#13: 
omara_13 <- omara %>% filter(chromosome == 13) 
phelan_13 <- read.table("Summary_chr13.txt", header=TRUE, sep=",") 
lawrenson_13 <- read.table("SummaryResults_Asian_chr13.txt", header=TRUE, sep=",") 
ukbb_13 <- filter(ukbb, grepl("^13:", chrpos)) 
phelan_13$chrpos <- paste(phelan_13$Chromosome, phelan_13$Position, sep=":") 
lawrenson_13$chrpos <- paste(lawrenson_13$Chromosome, lawrenson_13$Position, sep=":") 
 
omara_13 <- filter(omara_13, !grepl("NA", chrpos)) 
phelan_13 <- filter(phelan_13, !grepl("NA", chrpos)) 
lawrenson_13 <- filter(lawrenson_13, !grepl("NA", chrpos)) 
ukbb_13 <- filter(ukbb_13, !grepl("NA", chrpos)) 
 
phelan_13 <- phelan_13 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_13 <- lawrenson_13 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_13 <- omara_13[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_13 <- lawrenson_13[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_13 <- phelan_13[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_13 <- ukbb_13[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_13, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr13\\omara_13.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_13, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr13\\lawrenson_13.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_13, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr13\\phelan_13.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_13, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr13\\ukbb_13.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_13','lawrenson_13','phelan_13','ukbb_13')) 
#14: 
omara_14 <- omara %>% filter(chromosome == 14) 
phelan_14 <- read.table("Summary_chr14.txt", header=TRUE, sep=",") 
lawrenson_14 <- read.table("SummaryResults_Asian_chr14.txt", header=TRUE, sep=",") 
ukbb_14 <- filter(ukbb, grepl("^14:", chrpos)) 
phelan_14$chrpos <- paste(phelan_14$Chromosome, phelan_14$Position, sep=":") 
lawrenson_14$chrpos <- paste(lawrenson_14$Chromosome, lawrenson_14$Position, sep=":") 
 
omara_14 <- filter(omara_14, !grepl("NA", chrpos)) 
phelan_14 <- filter(phelan_14, !grepl("NA", chrpos)) 
lawrenson_14 <- filter(lawrenson_14, !grepl("NA", chrpos)) 
ukbb_14 <- filter(ukbb_14, !grepl("NA", chrpos)) 
 
phelan_14 <- phelan_14 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
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                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_14 <- lawrenson_14 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_14 <- omara_14[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_14 <- lawrenson_14[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_14 <- phelan_14[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_14 <- ukbb_14[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_14, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr14\\omara_14.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_14, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr14\\lawrenson_14.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_14, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr14\\phelan_14.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_14, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr14\\ukbb_14.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_14','lawrenson_14','phelan_14','ukbb_14')) 
#15: 
omara_15 <- omara %>% filter(chromosome == 15) 
phelan_15 <- read.table("Summary_chr15.txt", header=TRUE, sep=",") 
lawrenson_15 <- read.table("SummaryResults_Asian_chr15.txt", header=TRUE, sep=",") 
ukbb_15 <- filter(ukbb, grepl("^15:", chrpos)) 
phelan_15$chrpos <- paste(phelan_15$Chromosome, phelan_15$Position, sep=":") 
lawrenson_15$chrpos <- paste(lawrenson_15$Chromosome, lawrenson_15$Position, sep=":") 
 
omara_15 <- filter(omara_15, !grepl("NA", chrpos)) 
phelan_15 <- filter(phelan_15, !grepl("NA", chrpos)) 
lawrenson_15 <- filter(lawrenson_15, !grepl("NA", chrpos)) 
ukbb_15 <- filter(ukbb_15, !grepl("NA", chrpos)) 
 
phelan_15 <- phelan_15 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_15 <- lawrenson_15 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_15 <- omara_15[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_15 <- lawrenson_15[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_15 <- phelan_15[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_15 <- ukbb_15[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_15, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr15\\omara_15.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_15, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr15\\lawrenson_15.txt", 




write.table(phelan_15, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr15\\phelan_15.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_15, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr15\\ukbb_15.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_15','lawrenson_15','phelan_15','ukbb_15')) 
#16: 
omara_16 <- omara %>% filter(chromosome == 16) 
phelan_16 <- read.table("Summary_chr16.txt", header=TRUE, sep=",") 
lawrenson_16 <- read.table("SummaryResults_Asian_chr16.txt", header=TRUE, sep=",") 
ukbb_16 <- filter(ukbb, grepl("^16:", chrpos)) 
phelan_16$chrpos <- paste(phelan_16$Chromosome, phelan_16$Position, sep=":") 
lawrenson_16$chrpos <- paste(lawrenson_16$Chromosome, lawrenson_16$Position, sep=":") 
 
omara_16 <- filter(omara_16, !grepl("NA", chrpos)) 
phelan_16 <- filter(phelan_16, !grepl("NA", chrpos)) 
lawrenson_16 <- filter(lawrenson_16, !grepl("NA", chrpos)) 
ukbb_16 <- filter(ukbb_16, !grepl("NA", chrpos)) 
 
phelan_16 <- phelan_16 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_16 <- lawrenson_16 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_16 <- omara_16[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_16 <- lawrenson_16[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_16 <- phelan_16[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_16 <- ukbb_16[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_16, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr16\\omara_16.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_16, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr16\\lawrenson_16.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_16, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr16\\phelan_16.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_16, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr16\\ukbb_16.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_16','lawrenson_16','phelan_16','ukbb_16')) 
#17: 
omara_17 <- omara %>% filter(chromosome == 17) 
phelan_17 <- read.table("Summary_chr17.txt", header=TRUE, sep=",") 
lawrenson_17 <- read.table("SummaryResults_Asian_chr17.txt", header=TRUE, sep=",") 
ukbb_17 <- filter(ukbb, grepl("^17:", chrpos)) 
phelan_17$chrpos <- paste(phelan_17$Chromosome, phelan_17$Position, sep=":") 
lawrenson_17$chrpos <- paste(lawrenson_17$Chromosome, lawrenson_17$Position, sep=":") 
 
omara_17 <- filter(omara_17, !grepl("NA", chrpos)) 
phelan_17 <- filter(phelan_17, !grepl("NA", chrpos)) 
lawrenson_17 <- filter(lawrenson_17, !grepl("NA", chrpos)) 
ukbb_17 <- filter(ukbb_17, !grepl("NA", chrpos)) 
 
phelan_17 <- phelan_17 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
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                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_17 <- lawrenson_17 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_17 <- omara_17[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_17 <- lawrenson_17[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_17 <- phelan_17[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_17 <- ukbb_17[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_17, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr17\\omara_17.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_17, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr17\\lawrenson_17.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_17, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr17\\phelan_17.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_17, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr17\\ukbb_17.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_17','lawrenson_17','phelan_17','ukbb_17')) 
#18: 
omara_18 <- omara %>% filter(chromosome == 18) 
phelan_18 <- read.table("Summary_chr18.txt", header=TRUE, sep=",") 
lawrenson_18 <- read.table("SummaryResults_Asian_chr18.txt", header=TRUE, sep=",") 
ukbb_18 <- filter(ukbb, grepl("^18:", chrpos)) 
phelan_18$chrpos <- paste(phelan_18$Chromosome, phelan_18$Position, sep=":") 
lawrenson_18$chrpos <- paste(lawrenson_18$Chromosome, lawrenson_18$Position, sep=":") 
 
omara_18 <- filter(omara_18, !grepl("NA", chrpos)) 
phelan_18 <- filter(phelan_18, !grepl("NA", chrpos)) 
lawrenson_18 <- filter(lawrenson_18, !grepl("NA", chrpos)) 
ukbb_18 <- filter(ukbb_18, !grepl("NA", chrpos)) 
 
phelan_18 <- phelan_18 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_18 <- lawrenson_18 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_18 <- omara_18[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_18 <- lawrenson_18[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_18 <- phelan_18[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_18 <- ukbb_18[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_18, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr18\\omara_18.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_18, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr18\\lawrenson_18.txt", 




write.table(phelan_18, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr18\\phelan_18.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_18, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr18\\ukbb_18.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_18','lawrenson_18','phelan_18','ukbb_18')) 
#19: 
omara_19 <- omara %>% filter(chromosome == 19) 
phelan_19 <- read.table("Summary_chr19.txt", header=TRUE, sep=",") 
lawrenson_19 <- read.table("SummaryResults_Asian_chr19.txt", header=TRUE, sep=",") 
ukbb_19 <- filter(ukbb, grepl("^19:", chrpos)) 
phelan_19$chrpos <- paste(phelan_19$Chromosome, phelan_19$Position, sep=":") 
lawrenson_19$chrpos <- paste(lawrenson_19$Chromosome, lawrenson_19$Position, sep=":") 
 
omara_19 <- filter(omara_19, !grepl("NA", chrpos)) 
phelan_19 <- filter(phelan_19, !grepl("NA", chrpos)) 
lawrenson_19 <- filter(lawrenson_19, !grepl("NA", chrpos)) 
ukbb_19 <- filter(ukbb_19, !grepl("NA", chrpos)) 
 
phelan_19 <- phelan_19 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_19 <- lawrenson_19 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_19 <- omara_19[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_19 <- lawrenson_19[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_19 <- phelan_19[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_19 <- ukbb_19[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_19, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr19\\omara_19.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_19, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr19\\lawrenson_19.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_19, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr19\\phelan_19.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_19, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr19\\ukbb_19.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_19','lawrenson_19','phelan_19','ukbb_19')) 
#20: 
omara_20 <- omara %>% filter(chromosome == 20) 
phelan_20 <- read.table("Summary_chr20.txt", header=TRUE, sep=",") 
lawrenson_20 <- read.table("SummaryResults_Asian_chr20.txt", header=TRUE, sep=",") 
ukbb_20 <- filter(ukbb, grepl("^20:", chrpos)) 
phelan_20$chrpos <- paste(phelan_20$Chromosome, phelan_20$Position, sep=":") 
lawrenson_20$chrpos <- paste(lawrenson_20$Chromosome, lawrenson_20$Position, sep=":") 
 
omara_20 <- filter(omara_20, !grepl("NA", chrpos)) 
phelan_20 <- filter(phelan_20, !grepl("NA", chrpos)) 
lawrenson_20 <- filter(lawrenson_20, !grepl("NA", chrpos)) 
ukbb_20 <- filter(ukbb_20, !grepl("NA", chrpos)) 
 
phelan_20 <- phelan_20 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
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                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_20 <- lawrenson_20 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_20 <- omara_20[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_20 <- lawrenson_20[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_20 <- phelan_20[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_20 <- ukbb_20[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_20, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr20\\omara_20.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_20, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr20\\lawrenson_20.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_20, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr20\\phelan_20.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_20, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr20\\ukbb_20.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_20','lawrenson_20','phelan_20','ukbb_20')) 
#21: 
omara_21 <- omara %>% filter(chromosome == 21) 
phelan_21 <- read.table("Summary_chr21.txt", header=TRUE, sep=",") 
lawrenson_21 <- read.table("SummaryResults_Asian_chr21.txt", header=TRUE, sep=",") 
ukbb_21 <- filter(ukbb, grepl("^21:", chrpos)) 
phelan_21$chrpos <- paste(phelan_21$Chromosome, phelan_21$Position, sep=":") 
lawrenson_21$chrpos <- paste(lawrenson_21$Chromosome, lawrenson_21$Position, sep=":") 
 
omara_21 <- filter(omara_21, !grepl("NA", chrpos)) 
phelan_21 <- filter(phelan_21, !grepl("NA", chrpos)) 
lawrenson_21 <- filter(lawrenson_21, !grepl("NA", chrpos)) 
ukbb_21 <- filter(ukbb_21, !grepl("NA", chrpos)) 
 
phelan_21 <- phelan_21 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_21 <- lawrenson_21 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_21 <- omara_21[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_21 <- lawrenson_21[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_21 <- phelan_21[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_21 <- ukbb_21[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_21, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr21\\omara_21.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_21, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr21\\lawrenson_21.txt", 




write.table(phelan_21, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr21\\phelan_21.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_21, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr21\\ukbb_21.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_21','lawrenson_21','phelan_21','ukbb_21')) 
#22: 
omara_22 <- omara %>% filter(chromosome == 22) 
phelan_22 <- read.table("Summary_chr22.txt", header=TRUE, sep=",") 
lawrenson_22 <- read.table("SummaryResults_Asian_chr22.txt", header=TRUE, sep=",") 
ukbb_22 <- filter(ukbb, grepl("^22:", chrpos)) 
phelan_22$chrpos <- paste(phelan_22$Chromosome, phelan_22$Position, sep=":") 
lawrenson_22$chrpos <- paste(lawrenson_22$Chromosome, lawrenson_22$Position, sep=":") 
 
omara_22 <- filter(omara_22, !grepl("NA", chrpos)) 
phelan_22 <- filter(phelan_22, !grepl("NA", chrpos)) 
lawrenson_22 <- filter(lawrenson_22, !grepl("NA", chrpos)) 
ukbb_22 <- filter(ukbb_22, !grepl("NA", chrpos)) 
 
phelan_22 <- phelan_22 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_22 <- lawrenson_22 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
omara_22 <- omara_22[,c(26,17,18,19,20,21)] 
#^ SNP, other allele & effect allele, beta, SE, p-val. 
 
lawrenson_22 <- lawrenson_22[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_22 <- phelan_22[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
ukbb_22 <- ukbb_22[,c(16,17,18,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, beta, SE, overall p-val. 
write.table(omara_22, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr22\\omara_22.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(lawrenson_22, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr22\\lawrenson_22.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 
write.table(phelan_22, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr22\\phelan_22.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
write.table(ukbb_22, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr22\\ukbb_22.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
rm(list = c('omara_22','lawrenson_22','phelan_22','ukbb_22')) 
#23: 
 
#omara_23 <- omara %>% filter(chromosome == 23) #NO data 
phelan_23 <- read.table("Summary_chr23.txt", header=TRUE, sep=",") 
lawrenson_23 <- read.table("SummaryResults_Asian_chr23.txt", header=TRUE, sep=",") 
#ukbb_23 <- filter(ukbb, grepl("^23:", chrpos)) #NO data 
phelan_23$chrpos <- paste(phelan_23$Chromosome, phelan_23$Position, sep=":") 
lawrenson_23$chrpos <- paste(lawrenson_23$Chromosome, lawrenson_23$Position, sep=":") 
 
phelan_23 <- filter(phelan_23, !grepl("NA", chrpos)) 
lawrenson_23 <- filter(lawrenson_23, !grepl("NA", chrpos)) 
 
phelan_23 <- phelan_23 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
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lawrenson_23 <- lawrenson_23 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_23 <- lawrenson_23[,c(41,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
 
phelan_23 <- phelan_23[,c(73,1,6,5,9,10,12)] 
#^ SNP, rs, baseline allele, effect allele, overall OR, overall SE, overall p-val. 
write.table(lawrenson_23, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr23\\lawrenson_23.txt", 
row.names=FALSE, col.names=TRUE, quote=FALSE) 
 









Ovarian + Endometrial META #### 
 
METAr1 <- read.table("META_Chr1_1.txt", header=TRUE, sep="\t") 
METAr1$chromosome <- 1 
 
METAr2 <- read.table("META_Chr2_1.txt", header=TRUE, sep="\t") 
METAr2$chromosome <- 2 
 
METAr3 <- read.table("META_Chr3_1.txt", header=TRUE, sep="\t") 
METAr3$chromosome <- 3 
 
METAr4 <- read.table("META_Chr4_1.txt", header=TRUE, sep="\t") 
METAr4$chromosome <- 4 
 
METAr5 <- read.table("META_Chr5_1.txt", header=TRUE, sep="\t") 
METAr5$chromosome <- 5 
 
METAr6 <- read.table("META_Chr6_1.txt", header=TRUE, sep="\t") 
METAr6$chromosome <- 6 
 
METAr7 <- read.table("META_Chr7_1.txt", header=TRUE, sep="\t") 
METAr7$chromosome <- 7 
 
METAr8 <- read.table("META_Chr8_1.txt", header=TRUE, sep="\t") 
METAr8$chromosome <- 8 
 
METAr9 <- read.table("META_Chr9_1.txt", header=TRUE, sep="\t") 
METAr9$chromosome <- 9 
 
METAr10 <- read.table("META_Chr10_1.txt", header=TRUE, sep="\t") 
METAr10$chromosome <- 10 
 
METAr11 <- read.table("META_Chr11_1.txt", header=TRUE, sep="\t") 
METAr11$chromosome <- 11 
 
METAr12 <- read.table("META_Chr12_1.txt", header=TRUE, sep="\t") 
METAr12$chromosome <- 12 
 
METAr13 <- read.table("META_Chr13_1.txt", header=TRUE, sep="\t") 
METAr13$chromosome <- 13 
 
METAr14 <- read.table("META_Chr14_1.txt", header=TRUE, sep="\t") 




METAr15 <- read.table("META_Chr15_1.txt", header=TRUE, sep="\t") 
METAr15$chromosome <- 15 
 
METAr16 <- read.table("META_Chr16_1.txt", header=TRUE, sep="\t") 
METAr16$chromosome <- 16 
 
METAr17 <- read.table("META_Chr17_1.txt", header=TRUE, sep="\t") 
METAr17$chromosome <- 17 
 
METAr18 <- read.table("META_Chr18_1.txt", header=TRUE, sep="\t") 
METAr18$chromosome <- 18 
 
METAr19 <- read.table("META_Chr19_1.txt", header=TRUE, sep="\t") 
METAr19$chromosome <- 19 
 
METAr20 <- read.table("META_Chr20_1.txt", header=TRUE, sep="\t") 
METAr20$chromosome <- 20 
 
METAr21 <- read.table("META_Chr21_1.txt", header=TRUE, sep="\t") 
METAr21$chromosome <- 21 
 
METAr22 <- read.table("META_Chr22_1.txt", header=TRUE, sep="\t") 
METAr22$chromosome <- 22 
METAr <- rbind(METAr1, METAr2, METAr3, METAr4, METAr5, METAr6, METAr7, METAr8, METAr9, 
METAr10, METAr11, METAr12, METAr13, 
               METAr14, METAr15, METAr16, METAr17, METAr18, METAr19, METAr20, METAr21, METAr22) 
rm(list = c('METAr1','METAr2','METAr3','METAr4','METAr5','METAr6', 
            'METAr7','METAr8','METAr9','METAr10','METAr11','METAr12', 
            'METAr13','METAr14','METAr15','METAr16','METAr17','METAr18', 
            'METAr19','METAr20','METAr21','METAr22')) 
METAr$Position <- gsub("^.*:", "", METAr$MarkerName) 
 
METAr$chromosome <- as.numeric(METAr$chromosome) 
METAr$Position <- as.numeric(METAr$Position) 
METAr <- arrange(METAr, chromosome, Position) 
 
METAr$chrposal <- paste(METAr$MarkerName, METAr$Allele2, sep="_") 
METAr$chrposal <- paste(METAr$chrposal, METAr$Allele1, sep="/" ) 
 
#Assessing number of missing underlying studies by marker: 
#Cut down SNPs to just those in at least 2 underlying studies (NO ovarian only): 
 
METAr$num_miss <- str_count(as.character(METAr$Direction), "\\?") 
METAr$oma_miss <- substr(METAr$Direction, 1, 1) 
METAr$rowID <- row.names(METAr) 
#Below line finds only ovarian estimates, that is, only non-ovarian SNP was missing: 
METAr_filtered <- METAr %>% filter(oma_miss == '?' & num_miss == 1) 
METAr <- METAr[!(METAr$rowID %in% METAr_filtered$rowID),] 
METAr <- METAr %>% filter(num_miss < 2) #can't be estimates from only one study 
 





METAr_sig <- filter(METAr, P.value <= 0.00000005) 
METAr_sig <- METAr_sig[,c(12:13,1:11)] 
 
 




omara_liftover <- omara_liftover %>% rename(base_pair_location=V3, variant_id=V4) 
 
omara <- as.data.frame(fread("harmonised.qc.tsv")) 
 
omara_merge <- merge(omara, omara_liftover[,c(3,4)], by="variant_id") 
 




omara$chrpos <- paste(omara$chromosome, omara$base_pair_location.y, sep=":") 




phelan_9 <- read.table("Summary_chr9.txt", header=TRUE, sep=",") 
phelan_9$chrpos <- paste(phelan_9$Chromosome, phelan_9$Position, sep=":") 
lawrenson_9 <- read.table("SummaryResults_Asian_chr9.txt", header=TRUE, sep=",") 
lawrenson_9$chrpos <- paste(lawrenson_9$Chromosome, lawrenson_9$Position, sep=":") 
 
phe9_fp1 <- filter(phelan_9, grepl("9:16889937", chrpos)) 
law9_fp1 <- filter(lawrenson_9, grepl("9:16889937", chrpos)) 
oma9_fp1 <- filter(omara, grepl("9:16889937", chrpos)) 
 
oma9_fp1 <- oma9_fp1[,c(26,15,25,17:18,16,19:21)] 
oma9_fp1$study <- "O'Mara (2018)" 
oma9_fp1$N.cases <- 12906 
oma9_fp1$N.controls <- 108979 
phe9_fp1 <- phe9_fp1[,c(73,3:7,9:10,12)] 
phe9_fp1$study <- "Phelan (2017)" 
phe9_fp1$N.cases <- 25509 
phe9_fp1$N.controls <- 40941 
law9_fp1 <- law9_fp1[,c(41,3:7,9:10,12)] 
law9_fp1$study <- "Lawrenson (2019)" 
law9_fp1$N.cases <- 7321 
law9_fp1$N.controls <- 4083 
 
oma9_fp1 <- oma9_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma9_fp1, phe9_fp1) 
combined1 <- rbind(combined1, law9_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_9_fp1 <- filter(METAr, chromosome == 9) 
METAr_9_fp1 <- filter(METAr_9_fp1, grepl("9:16889937", MarkerName)) 
METAr_9_fp1$study <- "Meta" 
METAr_9_fp1$N.cases <- oma9_fp1$N.cases + law9_fp1$N.cases + phe9_fp1$N.cases 
METAr_9_fp1$N.controls <- oma9_fp1$N.controls + law9_fp1$N.controls + phe9_fp1$N.controls 
METAr_9_fp1 <- METAr_9_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_9_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
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summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 9:16889937", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 3:156413477 
 
phelan_3 <- read.table("Summary_chr3.txt", header=TRUE, sep=",") 
phelan_3$chrpos <- paste(phelan_3$Chromosome, phelan_3$Position, sep=":") 
 
phe3_fp1 <- filter(phelan_3, grepl("3:156413477", chrpos)) 
oma3_fp1 <- filter(omara, grepl("3:156413477", chrpos)) 
 
oma3_fp1 <- oma3_fp1[,c(26,15,25,17:18,16,19:21)] 
oma3_fp1$study <- "O'Mara (2018)" 
oma3_fp1$N.cases <- 12906 
oma3_fp1$N.controls <- 108979 
phe3_fp1 <- phe3_fp1[,c(73,3:7,9:10,12)] 
phe3_fp1$study <- "Phelan (2017)" 
phe3_fp1$N.cases <- 25509 
phe3_fp1$N.controls <- 40941 
 
oma3_fp1 <- oma3_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma3_fp1, phe3_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_3_fp1 <- filter(METAr, chromosome == 3) 
METAr_3_fp1 <- filter(METAr_3_fp1, grepl("3:156413477", MarkerName)) 
METAr_3_fp1$study <- "Meta" 
METAr_3_fp1$N.cases <- oma3_fp1$N.cases + phe3_fp1$N.cases 
METAr_3_fp1$N.controls <- oma3_fp1$N.controls + phe3_fp1$N.controls 
METAr_3_fp1 <- METAr_3_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_3_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 3:156413477", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 





phelan_8 <- read.table("Summary_chr8.txt", header=TRUE, sep=",") 
phelan_8$chrpos <- paste(phelan_8$Chromosome, phelan_8$Position, sep=":") 
lawrenson_8 <- read.table("SummaryResults_Asian_chr8.txt", header=TRUE, sep=",") 
lawrenson_8$chrpos <- paste(lawrenson_8$Chromosome, lawrenson_8$Position, sep=":") 
 
phe8_fp1 <- filter(phelan_8, grepl("8:129541931", chrpos)) 
law8_fp1 <- filter(lawrenson_8, grepl("8:129541931", chrpos)) 
oma8_fp1 <- filter(omara, grepl("8:129541931", chrpos)) 
 
oma8_fp1 <- oma8_fp1[,c(26,15,25,17:18,16,19:21)] 
oma8_fp1$study <- "O'Mara (2018)" 
oma8_fp1$N.cases <- 12906 
oma8_fp1$N.controls <- 108979 
phe8_fp1 <- phe8_fp1[,c(73,3:7,9:10,12)] 
phe8_fp1$study <- "Phelan (2017)" 
phe8_fp1$N.cases <- 25509 
phe8_fp1$N.controls <- 40941 
law8_fp1 <- law8_fp1[,c(41,3:7,9:10,12)] 
law8_fp1$study <- "Lawrenson (2019)" 
law8_fp1$N.cases <- 7321 
law8_fp1$N.controls <- 4083 
 
oma8_fp1 <- oma8_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma8_fp1, phe8_fp1) 
combined1 <- rbind(combined1, law8_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_8_fp1 <- filter(METAr, chromosome == 8) 
METAr_8_fp1 <- filter(METAr_8_fp1, grepl("8:129541931", MarkerName)) 
METAr_8_fp1$study <- "Meta" 
METAr_8_fp1$N.cases <- oma8_fp1$N.cases + law8_fp1$N.cases + phe8_fp1$N.cases 
METAr_8_fp1$N.controls <- oma8_fp1$N.controls + law8_fp1$N.controls + phe8_fp1$N.controls 
METAr_8_fp1 <- METAr_8_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_8_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 8:129541931", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 5:1282319 
 
phelan_5 <- read.table("Summary_chr5.txt", header=TRUE, sep=",") 
phelan_5$chrpos <- paste(phelan_5$Chromosome, phelan_5$Position, sep=":") 
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lawrenson_5 <- read.table("SummaryResults_Asian_chr5.txt", header=TRUE, sep=",") 
lawrenson_5$chrpos <- paste(lawrenson_5$Chromosome, lawrenson_5$Position, sep=":") 
 
phe5_fp1 <- filter(phelan_5, grepl("5:1282319", chrpos)) 
law5_fp1 <- filter(lawrenson_5, grepl("5:1282319", chrpos)) 
oma5_fp1 <- filter(omara, grepl("5:1282319", chrpos)) 
 
oma5_fp1 <- oma5_fp1[,c(26,15,25,17:18,16,19:21)] 
oma5_fp1$study <- "O'Mara (2018)" 
oma5_fp1$N.cases <- 12906 
oma5_fp1$N.controls <- 108979 
phe5_fp1 <- phe5_fp1[,c(73,3:7,9:10,12)] 
phe5_fp1$study <- "Phelan (2017)" 
phe5_fp1$N.cases <- 25509 
phe5_fp1$N.controls <- 40941 
law5_fp1 <- law5_fp1[,c(41,3:7,9:10,12)] 
law5_fp1$study <- "Lawrenson (2019)" 
law5_fp1$N.cases <- 7321 
law5_fp1$N.controls <- 4083 
 
oma5_fp1 <- oma5_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
#Two entries containing phrase "5:1282319", subsetting: 
phe5_fp1 <- phe5_fp1[!(phe5_fp1$Baseline == "G"),] 
law5_fp1 <- law5_fp1[!(law5_fp1$Baseline == "G"),] 
oma5_fp1 <- oma5_fp1[!(oma5_fp1$Baseline == "G"),] 
 
combined1 <- rbind(oma5_fp1, phe5_fp1) 
combined1 <- rbind(combined1, law5_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_5_fp1 <- filter(METAr, chromosome == 5) 
METAr_5_fp1 <- filter(METAr_5_fp1, grepl("5:1282319", MarkerName)) 
 
METAr_5_fp1 <- METAr_5_fp1[!(METAr_5_fp1$Allele2 == "g"),] 
 
METAr_5_fp1$study <- "Meta" 
METAr_5_fp1$N.cases <- oma5_fp1$N.cases + law5_fp1$N.cases + phe5_fp1$N.cases 
METAr_5_fp1$N.controls <- oma5_fp1$N.controls + law5_fp1$N.controls + phe5_fp1$N.controls 
METAr_5_fp1 <- METAr_5_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_5_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 5:1282319", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 






phelan_2 <- read.table("Summary_chr2.txt", header=TRUE, sep=",") 
phelan_2$chrpos <- paste(phelan_2$Chromosome, phelan_2$Position, sep=":") 
lawrenson_2 <- read.table("SummaryResults_Asian_chr2.txt", header=TRUE, sep=",") 
lawrenson_2$chrpos <- paste(lawrenson_2$Chromosome, lawrenson_2$Position, sep=":") 
 
phe2_fp1 <- filter(phelan_2, grepl("2:177037831", chrpos)) 
law2_fp1 <- filter(lawrenson_2, grepl("2:177037831", chrpos)) 
oma2_fp1 <- filter(omara, grepl("2:177037831", chrpos)) 
 
oma2_fp1 <- oma2_fp1[,c(26,15,25,17:18,16,19:21)] 
oma2_fp1$study <- "O'Mara (2018)" 
oma2_fp1$N.cases <- 12906 
oma2_fp1$N.controls <- 108979 
phe2_fp1 <- phe2_fp1[,c(73,3:7,9:10,12)] 
phe2_fp1$study <- "Phelan (2017)" 
phe2_fp1$N.cases <- 25509 
phe2_fp1$N.controls <- 40941 
law2_fp1 <- law2_fp1[,c(41,3:7,9:10,12)] 
law2_fp1$study <- "Lawrenson (2019)" 
law2_fp1$N.cases <- 7321 
law2_fp1$N.controls <- 4083 
 
oma2_fp1 <- oma2_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma2_fp1, phe2_fp1) 
combined1 <- rbind(combined1, law2_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_fp1 <- filter(METAr, chromosome == 2) 
METAr_2_fp1 <- filter(METAr_2_fp1, grepl("2:177037831", MarkerName)) 
METAr_2_fp1$Effect <- -(as.numeric(METAr_2_fp1$Effect)) #Reversing direction 
#for Allele swap. 
 
METAr_2_fp1$study <- "Meta" 
METAr_2_fp1$N.cases <- oma2_fp1$N.cases + law2_fp1$N.cases + phe2_fp1$N.cases 
METAr_2_fp1$N.controls <- oma2_fp1$N.controls + law2_fp1$N.controls + phe2_fp1$N.controls 
METAr_2_fp1 <- METAr_2_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
                                                    #Account for allele swap^             
combined2 <- merge(combined1, METAr_2_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 2:177037831", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
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           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 8:82653644 
 
phelan_8 <- read.table("Summary_chr8.txt", header=TRUE, sep=",") 
phelan_8$chrpos <- paste(phelan_8$Chromosome, phelan_8$Position, sep=":") 
 
phe8_fp2 <- filter(phelan_8, grepl("8:82653644", chrpos)) 
oma8_fp2 <- filter(omara, grepl("8:82653644", chrpos)) 
 
oma8_fp2 <- oma8_fp2[,c(26,15,25,17:18,16,19:21)] 
oma8_fp2$study <- "O'Mara (2018)" 
oma8_fp2$N.cases <- 12906 
oma8_fp2$N.controls <- 108979 
phe8_fp2 <- phe8_fp2[,c(73,3:7,9:10,12)] 
phe8_fp2$study <- "Phelan (2017)" 
phe8_fp2$N.cases <- 25509 
phe8_fp2$N.controls <- 40941 
 
oma8_fp2 <- oma8_fp2 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma8_fp2, phe8_fp2) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_8_fp2 <- filter(METAr, chromosome == 8) 
METAr_8_fp2 <- filter(METAr_8_fp2, grepl("8:82653644", MarkerName)) 
METAr_8_fp2$Effect <- -(as.numeric(METAr_8_fp2$Effect)) #Reversing direction 
#for Allele swap. 
 
METAr_8_fp2$study <- "Meta" 
METAr_8_fp2$N.cases <- oma8_fp2$N.cases + phe8_fp2$N.cases 
METAr_8_fp2$N.controls <- oma8_fp2$N.controls + phe8_fp2$N.controls 
METAr_8_fp2 <- METAr_8_fp2 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
                                                    #Account for allele swap^             
 
combined2 <- merge(combined1, METAr_8_fp2, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 8:82653644", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 9:13615500 
 
phelan_9 <- read.table("Summary_chr9.txt", header=TRUE, sep=",") 
phelan_9$chrpos <- paste(phelan_9$Chromosome, phelan_9$Position, sep=":") 
lawrenson_9 <- read.table("SummaryResults_Asian_chr9.txt", header=TRUE, sep=",") 




phe9_fp2 <- filter(phelan_9, grepl("9:13615500", chrpos)) 
law9_fp2 <- filter(lawrenson_9, grepl("9:13615500", chrpos)) 
oma9_fp2 <- filter(omara, grepl("9:13615500", chrpos)) 
 
oma9_fp2 <- oma9_fp2[,c(26,15,25,17:18,16,19:21)] 
oma9_fp2$study <- "O'Mara (2018)" 
oma9_fp2$N.cases <- 12906 
oma9_fp2$N.controls <- 108979 
phe9_fp2 <- phe9_fp2[,c(73,3:7,9:10,12)] 
phe9_fp2$study <- "Phelan (2017)" 
phe9_fp2$N.cases <- 25509 
phe9_fp2$N.controls <- 40941 
law9_fp2 <- law9_fp2[,c(41,3:7,9:10,12)] 
law9_fp2$study <- "Lawrenson (2019)" 
law9_fp2$N.cases <- 7321 
law9_fp2$N.controls <- 4083 
 
oma9_fp2 <- oma9_fp2 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma9_fp2, phe9_fp2) 
combined1 <- rbind(combined1, law9_fp2) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_9_fp2 <- filter(METAr, chromosome == 9) 
METAr_9_fp2 <- filter(METAr_9_fp2, grepl("9:13615500", MarkerName)) 
METAr_9_fp2$study <- "Meta" 
METAr_9_fp2$N.cases <- oma9_fp2$N.cases + law9_fp2$N.cases + phe9_fp2$N.cases 
METAr_9_fp2$N.controls <- oma9_fp2$N.controls + law9_fp2$N.controls + phe9_fp2$N.controls 
METAr_9_fp2 <- METAr_9_fp2 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_9_fp2, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 9:13615500", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 10:21821274 
 
phelan_10 <- read.table("Summary_chr10.txt", header=TRUE, sep=",") 
phelan_10$chrpos <- paste(phelan_10$Chromosome, phelan_10$Position, sep=":") 
lawrenson_10 <- read.table("SummaryResults_Asian_chr10.txt", header=TRUE, sep=",") 
lawrenson_10$chrpos <- paste(lawrenson_10$Chromosome, lawrenson_10$Position, sep=":") 
 
phe10_fp1 <- filter(phelan_10, grepl("10:21821274", chrpos)) 
law10_fp1 <- filter(lawrenson_10, grepl("10:21821274", chrpos)) 
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oma10_fp1 <- filter(omara, grepl("10:21821274", chrpos)) 
 
oma10_fp1 <- oma10_fp1[,c(26,15,25,17:18,16,19:21)] 
oma10_fp1$study <- "O'Mara (2018)" 
oma10_fp1$N.cases <- 12906 
oma10_fp1$N.controls <- 108979 
phe10_fp1 <- phe10_fp1[,c(73,3:7,9:10,12)] 
phe10_fp1$study <- "Phelan (2017)" 
phe10_fp1$N.cases <- 25509 
phe10_fp1$N.controls <- 40941 
law10_fp1 <- law10_fp1[,c(41,3:7,9:10,12)] 
law10_fp1$study <- "Lawrenson (2019)" 
law10_fp1$N.cases <- 7321 
law10_fp1$N.controls <- 4083 
 
oma10_fp1 <- oma10_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma10_fp1, phe10_fp1) 
combined1 <- rbind(combined1, law10_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_10_fp1 <- filter(METAr, chromosome == 10) 
METAr_10_fp1 <- filter(METAr_10_fp1, grepl("10:21821274", MarkerName)) 
METAr_10_fp1$study <- "Meta" 
METAr_10_fp1$N.cases <- oma10_fp1$N.cases + law10_fp1$N.cases + phe10_fp1$N.cases 
METAr_10_fp1$N.controls <- oma10_fp1$N.controls + law10_fp1$N.controls + phe10_fp1$N.controls 
METAr_10_fp1 <- METAr_10_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_10_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 10:21821274", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 13:73814891 
 
phelan_13 <- read.table("Summary_chr13.txt", header=TRUE, sep=",") 
phelan_13$chrpos <- paste(phelan_13$Chromosome, phelan_13$Position, sep=":") 
lawrenson_13 <- read.table("SummaryResults_Asian_chr13.txt", header=TRUE, sep=",") 
lawrenson_13$chrpos <- paste(lawrenson_13$Chromosome, lawrenson_13$Position, sep=":") 
 
phe13_fp1 <- filter(phelan_13, grepl("13:73814891", chrpos)) 
law13_fp1 <- filter(lawrenson_13, grepl("13:73814891", chrpos)) 
oma13_fp1 <- filter(omara, grepl("13:73814891", chrpos)) 
 
oma13_fp1 <- oma13_fp1[,c(26,15,25,17:18,16,19:21)] 
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oma13_fp1$study <- "O'Mara (2018)" 
oma13_fp1$N.cases <- 12906 
oma13_fp1$N.controls <- 108979 
phe13_fp1 <- phe13_fp1[,c(73,3:7,9:10,12)] 
phe13_fp1$study <- "Phelan (2017)" 
phe13_fp1$N.cases <- 25509 
phe13_fp1$N.controls <- 40941 
law13_fp1 <- law13_fp1[,c(41,3:7,9:10,12)] 
law13_fp1$study <- "Lawrenson (2019)" 
law13_fp1$N.cases <- 7321 
law13_fp1$N.controls <- 4083 
 
oma13_fp1 <- oma13_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma13_fp1, phe13_fp1) 
combined1 <- rbind(combined1, law13_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_13_fp1 <- filter(METAr, chromosome == 13) 
METAr_13_fp1 <- filter(METAr_13_fp1, grepl("13:73814891", MarkerName)) 
METAr_13_fp1$study <- "Meta" 
METAr_13_fp1$N.cases <- oma13_fp1$N.cases + law13_fp1$N.cases + phe13_fp1$N.cases 
METAr_13_fp1$N.controls <- oma13_fp1$N.controls + law13_fp1$N.controls + phe13_fp1$N.controls 
METAr_13_fp1 <- METAr_13_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_13_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 13:73814891", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 17:29181220 
 
phelan_17 <- read.table("Summary_chr17.txt", header=TRUE, sep=",") 
phelan_17$chrpos <- paste(phelan_17$Chromosome, phelan_17$Position, sep=":") 
lawrenson_17 <- read.table("SummaryResults_Asian_chr17.txt", header=TRUE, sep=",") 
lawrenson_17$chrpos <- paste(lawrenson_17$Chromosome, lawrenson_17$Position, sep=":") 
 
phe17_fp1 <- filter(phelan_17, grepl("17:29181220", chrpos)) 
law17_fp1 <- filter(lawrenson_17, grepl("17:29181220", chrpos)) 
oma17_fp1 <- filter(omara, grepl("17:29181220", chrpos)) 
 
oma17_fp1 <- oma17_fp1[,c(26,15,25,17:18,16,19:21)] 
oma17_fp1$study <- "O'Mara (2018)" 
oma17_fp1$N.cases <- 12906 
oma17_fp1$N.controls <- 108979 
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phe17_fp1 <- phe17_fp1[,c(73,3:7,9:10,12)] 
phe17_fp1$study <- "Phelan (2017)" 
phe17_fp1$N.cases <- 25509 
phe17_fp1$N.controls <- 40941 
law17_fp1 <- law17_fp1[,c(41,3:7,9:10,12)] 
law17_fp1$study <- "Lawrenson (2019)" 
law17_fp1$N.cases <- 7321 
law17_fp1$N.controls <- 4083 
 
oma17_fp1 <- oma17_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma17_fp1, phe17_fp1) 
combined1 <- rbind(combined1, law17_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_17_fp1 <- filter(METAr, chromosome == 17) 
METAr_17_fp1 <- filter(METAr_17_fp1, grepl("17:29181220", MarkerName)) 
METAr_17_fp1$study <- "Meta" 
METAr_17_fp1$Effect <- -(as.numeric(METAr_17_fp1$Effect)) 
 
METAr_17_fp1$N.cases <- oma17_fp1$N.cases + law17_fp1$N.cases + phe17_fp1$N.cases 
METAr_17_fp1$N.controls <- oma17_fp1$N.controls + law17_fp1$N.controls + phe17_fp1$N.controls 
METAr_17_fp1 <- METAr_17_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
 
combined2 <- merge(combined1, METAr_17_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 17:29181220", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 17:44212527 
 
phelan_17 <- read.table("Summary_chr17.txt", header=TRUE, sep=",") 
phelan_17$chrpos <- paste(phelan_17$Chromosome, phelan_17$Position, sep=":") 
 
phe17_fp2 <- filter(phelan_17, grepl("17:44212527", chrpos)) 
oma17_fp2 <- filter(omara, grepl("17:44212527", chrpos)) 
#Two different results, METAL used first instance: 
oma17_fp2 <- filter(oma17_fp2, oma17_fp2$beta == -0.0276902) 
#Two identical rows, keeping first: 
oma17_fp2 <- oma17_fp2[1,] 
 
oma17_fp2 <- oma17_fp2[,c(26,15,25,17:18,16,19:21)] 
oma17_fp2$study <- "O'Mara (2018)" 
oma17_fp2$N.cases <- 12906 
oma17_fp2$N.controls <- 108979 
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phe17_fp2 <- phe17_fp2[,c(73,3:7,9:10,12)] 
phe17_fp2$study <- "Phelan (2017)" 
phe17_fp2$N.cases <- 25509 
phe17_fp2$N.controls <- 40941 
 
oma17_fp2 <- oma17_fp2 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma17_fp2, phe17_fp2) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_17_fp2 <- filter(METAr, chromosome == 17) 
METAr_17_fp2 <- filter(METAr_17_fp2, grepl("17:44212527", MarkerName)) 
METAr_17_fp2$Effect <- -(as.numeric(METAr_17_fp2$Effect)) #Reversing direction 
#for Allele swap. 
METAr_17_fp2$study <- "Meta" 
METAr_17_fp2$N.cases <- oma17_fp2$N.cases + phe17_fp2$N.cases 
METAr_17_fp2$N.controls <- oma17_fp2$N.controls + phe17_fp2$N.controls 
METAr_17_fp2 <- METAr_17_fp2 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
                                                          #Account for allele swap^ 
combined2 <- merge(combined1, METAr_17_fp2, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 17:44212527", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 19:17390917 
 
phelan_19 <- read.table("Summary_chr19.txt", header=TRUE, sep=",") 
phelan_19$chrpos <- paste(phelan_19$Chromosome, phelan_19$Position, sep=":") 
lawrenson_19 <- read.table("SummaryResults_Asian_chr19.txt", header=TRUE, sep=",") 
lawrenson_19$chrpos <- paste(lawrenson_19$Chromosome, lawrenson_19$Position, sep=":") 
 
phe19_fp1 <- filter(phelan_19, grepl("19:17390917", chrpos)) 
law19_fp1 <- filter(lawrenson_19, grepl("19:17390917", chrpos)) 
oma19_fp1 <- filter(omara, grepl("19:17390917", chrpos)) 
 
oma19_fp1 <- oma19_fp1[,c(26,15,25,17:18,16,19:21)] 
oma19_fp1$study <- "O'Mara (2018)" 
oma19_fp1$N.cases <- 12906 
oma19_fp1$N.controls <- 108979 
phe19_fp1 <- phe19_fp1[,c(73,3:7,9:10,12)] 
phe19_fp1$study <- "Phelan (2017)" 
phe19_fp1$N.cases <- 25509 
phe19_fp1$N.controls <- 40941 
law19_fp1 <- law19_fp1[,c(41,3:7,9:10,12)] 
law19_fp1$study <- "Lawrenson (2019)" 
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law19_fp1$N.cases <- 7321 
law19_fp1$N.controls <- 4083 
 
oma19_fp1 <- oma19_fp1 %>% rename(Chromosome=chromosome, Position=base_pair_location, 
                                Effect=effect_allele, Baseline=other_allele, 
                                EAF=effect_allele_frequency, overall_OR = beta, 
                                overall_SE=standard_error, overall_pvalue=p_value) 
 
combined1 <- rbind(oma19_fp1, phe19_fp1) 
combined1 <- rbind(combined1, law19_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_19_fp1 <- filter(METAr, chromosome == 19) 
METAr_19_fp1 <- filter(METAr_19_fp1, grepl("19:17390917", MarkerName)) 
METAr_19_fp1$study <- "Meta" 
METAr_19_fp1$N.cases <- oma19_fp1$N.cases + law19_fp1$N.cases + phe19_fp1$N.cases 
METAr_19_fp1$N.controls <- oma19_fp1$N.controls + law19_fp1$N.controls + phe19_fp1$N.controls 
METAr_19_fp1 <- METAr_19_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_19_fp1, all=TRUE) 
ordervec <- c("O'Mara (2018)", "Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 19:17390917", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#Make tables for significant results, alongside input alleles: 
#^ Filtering 2,155 observations just to select SNPs: 
alleleframe <- METAr_sig[c(METAr_sig$MarkerName %in% c("2:177037831", "3:156413477", "5:1282319",  
                                             "8:82653644", "8:129541931", "9:136155000", 
                                               "9:16889937", "10:21821274", "13:73814891",  
                                             "17:29181220", "17:44212527", "19:17390917")),] 
omara_alleles <- filter(omara, omara$chrpos %in% alleleframe$MarkerName) 
omara_alleles <- omara_alleles[,c(26,17:18)] 
alleleframe <- merge(alleleframe, omara_alleles, by.x="MarkerName", by.y="chrpos", all.x=TRUE) 
alleleframe <- alleleframe[,c(1:3,14:15,4:13)] 
 
 
alleleframe <- alleleframe %>% rename(SNP=MarkerName, `Input Effect Allele` = effect_allele, 
                                        `Input Base Allele` = other_allele, `Output Effect Allele` = Allele1, 
                                        `Output Base Allele` = Allele2, Beta = Effect, SE=StdErr, 
                                        `P-Value` = P.value, `Het. I-Squared` = HetISq, `Het. Chi-Squared` = HetChiSq, 
                                        `Het. DF` = HetDf, `Het. P-Value` = HetPVal, Chromosome = chromosome) 
alleleframe <- arrange(alleleframe, alleleframe$Chromosome, alleleframe$Position) 
alleleframe$`Output Effect Allele` <- toupper(alleleframe$`Output Effect Allele`) 
alleleframe$`Output Base Allele` <- toupper(alleleframe$`Output Base Allele`) 
 
alleleframe_res <- alleleframe[,c(1:11)] 






invisible(stargazer(alleleframe_res, type="html", summary=FALSE, rownames=FALSE, 
out="ovarendo_meta_results_table.doc",  
          title="Ovarian+Endometrial Meta-Analysis Significant Results")) 
invisible(stargazer(alleleframe_het, type="html", summary=FALSE, rownames=FALSE, 
out="ovarendo_meta_results_table_2.doc",  
          title="Ovarian+Endometrial Meta-Analysis Significant Results - Heterogeneity Test")) 
Ovarian + Cervical META #### 
 
METAr1_c <- read.table("META_Chr1_c_1.txt", header=TRUE, sep="\t") 
METAr1_c$chromosome <- 1 
 
METAr2_c <- read.table("META_Chr2_c_1.txt", header=TRUE, sep="\t") 
METAr2_c$chromosome <- 2 
 
METAr3_c <- read.table("META_Chr3_c_1.txt", header=TRUE, sep="\t") 
METAr3_c$chromosome <- 3 
 
METAr4_c <- read.table("META_Chr4_c_1.txt", header=TRUE, sep="\t") 
METAr4_c$chromosome <- 4 
 
METAr5_c <- read.table("META_Chr5_c_1.txt", header=TRUE, sep="\t") 
METAr5_c$chromosome <- 5 
 
METAr6_c <- read.table("META_Chr6_c_1.txt", header=TRUE, sep="\t") 
METAr6_c$chromosome <- 6 
 
METAr7_c <- read.table("META_Chr7_c_1.txt", header=TRUE, sep="\t") 
METAr7_c$chromosome <- 7 
 
METAr8_c <- read.table("META_Chr8_c_1.txt", header=TRUE, sep="\t") 
METAr8_c$chromosome <- 8 
 
METAr9_c <- read.table("META_Chr9_c_1.txt", header=TRUE, sep="\t") 
METAr9_c$chromosome <- 9 
 
METAr10_c <- read.table("META_Chr10_c_1.txt", header=TRUE, sep="\t") 
METAr10_c$chromosome <- 10 
 
METAr11_c <- read.table("META_Chr11_c_1.txt", header=TRUE, sep="\t") 
METAr11_c$chromosome <- 11 
 
METAr12_c <- read.table("META_Chr12_c_1.txt", header=TRUE, sep="\t") 
METAr12_c$chromosome <- 12 
 
METAr13_c <- read.table("META_Chr13_c_1.txt", header=TRUE, sep="\t") 
METAr13_c$chromosome <- 13 
 
METAr14_c <- read.table("META_Chr14_c_1.txt", header=TRUE, sep="\t") 
METAr14_c$chromosome <- 14 
 
METAr15_c <- read.table("META_Chr15_c_1.txt", header=TRUE, sep="\t") 
METAr15_c$chromosome <- 15 
 
METAr16_c <- read.table("META_Chr16_c_1.txt", header=TRUE, sep="\t") 
METAr16_c$chromosome <- 16 
 
METAr17_c <- read.table("META_Chr17_c_1.txt", header=TRUE, sep="\t") 
METAr17_c$chromosome <- 17 
 
METAr18_c <- read.table("META_Chr18_c_1.txt", header=TRUE, sep="\t") 
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METAr18_c$chromosome <- 18 
 
METAr19_c <- read.table("META_Chr19_c_1.txt", header=TRUE, sep="\t") 
METAr19_c$chromosome <- 19 
 
METAr20_c <- read.table("META_Chr20_c_1.txt", header=TRUE, sep="\t") 
METAr20_c$chromosome <- 20 
 
METAr21_c <- read.table("META_Chr21_c_1.txt", header=TRUE, sep="\t") 
METAr21_c$chromosome <- 21 
 
METAr22_c <- read.table("META_Chr22_c_1.txt", header=TRUE, sep="\t") 
METAr22_c$chromosome <- 22 
METAr_c <- rbind(METAr1_c, METAr2_c, METAr3_c, METAr4_c, METAr5_c, METAr6_c, METAr7_c, 
METAr8_c, METAr9_c, METAr10_c, METAr11_c, METAr12_c, METAr13_c, METAr14_c, METAr15_c, METAr16_c, 
METAr17_c, METAr18_c, METAr19_c, METAr20_c, METAr21_c, METAr22_c) 
rm(list = c('METAr1_c','METAr2_c','METAr3_c','METAr4_c','METAr5_c','METAr6_c', 
            'METAr7_c','METAr8_c','METAr9_c','METAr10_c','METAr11_c','METAr12_c', 
            'METAr13_c','METAr14_c','METAr15_c','METAr16_c','METAr17_c','METAr18_c', 
            'METAr19_c','METAr20_c','METAr21_c','METAr22_c')) 
METAr_c$Position <- gsub("^.*:", "", METAr_c$MarkerName) 
 
METAr_c$chromosome <- as.numeric(METAr_c$chromosome) 
METAr_c$Position <- as.numeric(METAr_c$Position) 
METAr_c <- arrange(METAr_c, chromosome, Position) 
 
METAr_c$chrposal <- paste(METAr_c$MarkerName, METAr_c$Allele2, sep="_") 
METAr_c$chrposal <- paste(METAr_c$chrposal, METAr_c$Allele1, sep="/" ) 
 
#Assessing number of missing underlying studies by marker: 
#Cut down SNPs to just those in at least 2 underlying studies (NO ovarian only): 
 
METAr_c$num_miss <- str_count(as.character(METAr_c$Direction), "\\?") 
METAr_c$ukb_miss <- substr(METAr_c$Direction, 1, 1) 
METAr_c$rowID <- row.names(METAr_c) 
 
METAr_c_filtered <- METAr_c %>% filter(ukb_miss == '?' & num_miss == 1) 
METAr_c <- METAr_c[!(METAr_c$rowID %in% METAr_c_filtered$rowID),] 
METAr_c <- METAr_c %>% filter(num_miss < 2) #can't be estimates from only one study 
 





METAr_c_sig <- filter(METAr_c, P.value <= 0.00000005) 
METAr_c_sig <- METAr_c_sig[,c(12:13,1:11)] 
ukbb <- as.data.frame(fread("C53.gwas.imputed_v3.female.tsv")) 
#Mapping UKBB rsIDs: 
ukvariants <- as.data.frame(fread("variants.tsv")) 
ukvariants$chrpos <- paste(ukvariants$chr, ukvariants$pos, sep=":") 





#Filter MAF < 0.01, nonsense p-val,se: 
ukbb <- ukbb %>% filter(minor_AF > 0.01) %>% filter(se > 0) %>%  
                  filter(pval < 1 & pval > 0) 
 






phelan_12 <- read.table("Summary_chr12.txt", header=TRUE, sep=",") 
phelan_12$chrpos <- paste(phelan_12$Chromosome, phelan_12$Position, sep=":") 
 
phe12_fp1 <- filter(phelan_12, grepl("12:121056263", chrpos)) 
ukb12_fp1 <- filter(ukbb, grepl("12:121056263", chrpos)) 
 
ukb12_fp1 <- ukb12_fp1[,c(16,14:15,18,17,3,9:10,12)] 
ukb12_fp1$study <- "UK Biobank (2018)" 
ukb12_fp1$N.cases <- 192 
ukb12_fp1$N.controls <- 193982 
phe12_fp1 <- phe12_fp1[,c(73,3:7,9:10,12)] 
phe12_fp1$study <- "Phelan (2017)" 
phe12_fp1$N.cases <- 25509 
phe12_fp1$N.controls <- 40941 
 
ukb12_fp1 <- ukb12_fp1 %>% rename(Chromosome=chr, Position=pos, 
                                Effect=alt, Baseline=ref, 
                                EAF=minor_AF, overall_OR = beta, 
                                overall_SE=se, overall_pvalue=pval) 
 
combined1 <- rbind(ukb12_fp1, phe12_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_c_12_fp1 <- filter(METAr_c, chromosome == 12) 
METAr_c_12_fp1 <- filter(METAr_c_12_fp1, grepl("12:121056263", MarkerName)) 
METAr_c_12_fp1$study <- "Meta" 
METAr_c_12_fp1$N.cases <- ukb12_fp1$N.cases + phe12_fp1$N.cases 
METAr_c_12_fp1$N.controls <- ukb12_fp1$N.controls + phe12_fp1$N.controls 
METAr_c_12_fp1 <- METAr_c_12_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_c_12_fp1, all=TRUE) 
ordervec <- c("UK Biobank (2018)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           x_limit = c(-0.01,0.0099), 
           xlab="OR SNP 12:121056263", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 12:31954662 
 
phe12_fp1 <- filter(phelan_12, grepl("12:31954662", chrpos)) 
ukb12_fp1 <- filter(ukbb, grepl("12:31954662", chrpos)) 
 
ukb12_fp1 <- ukb12_fp1[,c(16,14:15,18,17,3,9:10,12)] 
ukb12_fp1$study <- "UK Biobank (2018)" 
ukb12_fp1$N.cases <- 192 
ukb12_fp1$N.controls <- 193982 
phe12_fp1 <- phe12_fp1[,c(73,3:7,9:10,12)] 
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phe12_fp1$study <- "Phelan (2017)" 
phe12_fp1$N.cases <- 25509 
phe12_fp1$N.controls <- 40941 
 
ukb12_fp1 <- ukb12_fp1 %>% rename(Chromosome=chr, Position=pos, 
                                Effect=alt, Baseline=ref, 
                                EAF=minor_AF, overall_OR = beta, 
                                overall_SE=se, overall_pvalue=pval) 
 
combined1 <- rbind(ukb12_fp1, phe12_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_c_12_fp1 <- filter(METAr_c, chromosome == 12) 
METAr_c_12_fp1 <- filter(METAr_c_12_fp1, grepl("12:31954662", MarkerName)) 
METAr_c_12_fp1$Effect <- -(as.numeric(METAr_c_12_fp1$Effect)) 
METAr_c_12_fp1$study <- "Meta" 
METAr_c_12_fp1$N.cases <- ukb12_fp1$N.cases + phe12_fp1$N.cases 
METAr_c_12_fp1$N.controls <- ukb12_fp1$N.controls + phe12_fp1$N.controls 
METAr_c_12_fp1 <- METAr_c_12_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
 
combined2 <- merge(combined1, METAr_c_12_fp1, all=TRUE) 
ordervec <- c("UK Biobank (2018)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           x_limit = c(-0.01,0.0099), 
           xlab="OR SNP 12:31954662", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 18:31370348 
 
phelan_18 <- read.table("Summary_chr18.txt", header=TRUE, sep=",") 
phelan_18$chrpos <- paste(phelan_18$Chromosome, phelan_18$Position, sep=":") 
 
phe18_fp1 <- filter(phelan_18, grepl("18:31370348", chrpos)) 
ukb18_fp1 <- filter(ukbb, grepl("18:31370348", chrpos)) 
 
ukb18_fp1 <- ukb18_fp1[,c(16,14:15,18,17,3,9:10,12)] 
ukb18_fp1$study <- "UK Biobank (2018)" 
ukb18_fp1$N.cases <- 192 
ukb18_fp1$N.controls <- 193982 
phe18_fp1 <- phe18_fp1[,c(73,3:7,9:10,12)] 
phe18_fp1$study <- "Phelan (2017)" 
phe18_fp1$N.cases <- 25509 
phe18_fp1$N.controls <- 40941 
 
ukb18_fp1 <- ukb18_fp1 %>% rename(Chromosome=chr, Position=pos, 
                                Effect=alt, Baseline=ref, 
                                EAF=minor_AF, overall_OR = beta, 




combined1 <- rbind(ukb18_fp1, phe18_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_c_18_fp1 <- filter(METAr_c, chromosome == 18) 
METAr_c_18_fp1 <- filter(METAr_c_18_fp1, grepl("18:31370348", MarkerName)) 
METAr_c_18_fp1$study <- "Meta" 
METAr_c_18_fp1$N.cases <- ukb18_fp1$N.cases + phe18_fp1$N.cases 
METAr_c_18_fp1$N.controls <- ukb18_fp1$N.controls + phe18_fp1$N.controls 
METAr_c_18_fp1 <- METAr_c_18_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_c_18_fp1, all=TRUE) 
ordervec <- c("UK Biobank (2018)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           x_limit=c(-0.01,0.0099), 
           xlab="OR SNP 18:31370348", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 6:66363605 
 
phelan_6 <- read.table("Summary_chr6.txt", header=TRUE, sep=",") 
phelan_6$chrpos <- paste(phelan_6$Chromosome, phelan_6$Position, sep=":") 
 
phe6_fp1 <- filter(phelan_6, grepl("6:66363605", chrpos)) 
ukb6_fp1 <- filter(ukbb, grepl("6:66363605", chrpos)) 
 
ukb6_fp1 <- ukb6_fp1[,c(16,14:15,18,17,3,9:10,12)] 
ukb6_fp1$study <- "UK Biobank (2018)" 
ukb6_fp1$N.cases <- 192 
ukb6_fp1$N.controls <- 193982 
phe6_fp1 <- phe6_fp1[,c(73,3:7,9:10,12)] 
phe6_fp1$study <- "Phelan (2017)" 
phe6_fp1$N.cases <- 25509 
phe6_fp1$N.controls <- 40941 
 
ukb6_fp1 <- ukb6_fp1 %>% rename(Chromosome=chr, Position=pos, 
                                Effect=alt, Baseline=ref, 
                                EAF=minor_AF, overall_OR = beta, 
                                overall_SE=se, overall_pvalue=pval) 
 
combined1 <- rbind(ukb6_fp1, phe6_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_c_6_fp1 <- filter(METAr_c, chromosome == 6) 
METAr_c_6_fp1 <- filter(METAr_c_6_fp1, grepl("6:66363605", MarkerName)) 
METAr_c_6_fp1$study <- "Meta" 
METAr_c_6_fp1$N.cases <- ukb6_fp1$N.cases + phe6_fp1$N.cases 
METAr_c_6_fp1$N.controls <- ukb6_fp1$N.controls + phe6_fp1$N.controls 
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METAr_c_6_fp1 <- METAr_c_6_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_c_6_fp1, all=TRUE) 
ordervec <- c("UK Biobank (2018)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,23)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           x_limit = c(-0.01,0.0099), 
           xlab="OR SNP 6:66363605", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#Make tables for significant results, alongside input alleles: 
alleleframe <- METAr_c_sig 
ukbb_alleles <- filter(ukbb, ukbb$chrpos %in% alleleframe$MarkerName) 
ukbb_alleles <- ukbb_alleles[,c(16:18)] 
alleleframe <- merge(alleleframe, ukbb_alleles, by.x="MarkerName", by.y="chrpos", all.x=TRUE) 
alleleframe <- alleleframe[,c(1:3,14:15,4:13)] 
 
 
alleleframe <- alleleframe %>% rename(SNP=MarkerName, `Input Effect Allele` = alt, 
                                        `Input Base Allele` = ref, `Output Effect Allele` = Allele1, 
                                        `Output Base Allele` = Allele2, Beta = Effect, SE=StdErr, 
                                        `P-Value` = P.value, `Het. I-Squared` = HetISq, `Het. Chi-Squared` = HetChiSq, 
                                        `Het. DF` = HetDf, `Het. P-Value` = HetPVal, Chromosome = chromosome) 
alleleframe <- arrange(alleleframe, alleleframe$Chromosome, alleleframe$Position) 
alleleframe$`Output Effect Allele` <- toupper(alleleframe$`Output Effect Allele`) 
alleleframe$`Output Base Allele` <- toupper(alleleframe$`Output Base Allele`) 
 
alleleframe_res <- alleleframe[,c(1:11)] 




stargazer(alleleframe_res, type="html", summary=FALSE, rownames=FALSE, out="ovarcerv_meta_results_table.doc",  
          title="Ovarian+Cervical Meta-Analysis Significant Results") 
stargazer(alleleframe_het, type="html", summary=FALSE, rownames=FALSE, 
out="ovarcerv_meta_results_table_2.doc",  
          title="Ovarian+Cervical Meta-Analysis Significant Results - Heterogeneity Test") 





ukbb <- as.data.frame(fread("C56.gwas.imputed_v3.female.tsv")) 
#Mapping UKBB rsIDs: 
ukvariants <- as.data.frame(fread("variants.tsv")) 
ukvariants$chrpos <- paste(ukvariants$chr, ukvariants$pos, sep=":") 





#Filter MAF < 0.01, nonsense p-val,se: 
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ukbb <- ukbb %>% filter(minor_AF > 0.01) %>% filter(se > 0) %>%  
                  filter(pval < 1 & pval > 0) 
 
ukbb <- arrange(ukbb, chr, pos) 
#Write out pretest for ovarian version of UKBB: 
#write.table(ukbb, sep="\t", file="C:\\Users\\Mark\\Documents\\ukbb_ovar_pretest.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
ukbb_1 <- filter(ukbb, grepl("^1:", chrpos)) 
ukbb_1 <- filter(ukbb_1, !grepl("NA", chrpos)) 
ukbb_1 <- ukbb_1[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_1, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr1\\ukbb_2_1.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_2 <- filter(ukbb, grepl("^2:", chrpos)) 
ukbb_2 <- filter(ukbb_2, !grepl("NA", chrpos)) 
ukbb_2 <- ukbb_2[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_2, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr2\\ukbb_2_2.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_3 <- filter(ukbb, grepl("^3:", chrpos)) 
ukbb_3 <- filter(ukbb_3, !grepl("NA", chrpos)) 
ukbb_3 <- ukbb_3[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_3, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr3\\ukbb_2_3.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_4 <- filter(ukbb, grepl("^4:", chrpos)) 
ukbb_4 <- filter(ukbb_4, !grepl("NA", chrpos)) 
ukbb_4 <- ukbb_4[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_4, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr4\\ukbb_2_4.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_5 <- filter(ukbb, grepl("^5:", chrpos)) 
ukbb_5 <- filter(ukbb_5, !grepl("NA", chrpos)) 
ukbb_5 <- ukbb_5[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_5, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr5\\ukbb_2_5.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_6 <- filter(ukbb, grepl("^6:", chrpos)) 
ukbb_6 <- filter(ukbb_6, !grepl("NA", chrpos)) 
ukbb_6 <- ukbb_6[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_6, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr6\\ukbb_2_6.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_7 <- filter(ukbb, grepl("^7:", chrpos)) 
ukbb_7 <- filter(ukbb_7, !grepl("NA", chrpos)) 
ukbb_7 <- ukbb_7[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_7, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr7\\ukbb_2_7.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_8 <- filter(ukbb, grepl("^8:", chrpos)) 
ukbb_8 <- filter(ukbb_8, !grepl("NA", chrpos)) 
ukbb_8 <- ukbb_8[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_8, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr8\\ukbb_2_8.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_9 <- filter(ukbb, grepl("^9:", chrpos)) 
ukbb_9 <- filter(ukbb_9, !grepl("NA", chrpos)) 
ukbb_9 <- ukbb_9[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_9, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr9\\ukbb_2_9.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_10 <- filter(ukbb, grepl("^10:", chrpos)) 
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ukbb_10 <- filter(ukbb_10, !grepl("NA", chrpos)) 
ukbb_10 <- ukbb_10[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_10, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr10\\ukbb_2_10.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_11 <- filter(ukbb, grepl("^11:", chrpos)) 
ukbb_11 <- filter(ukbb_11, !grepl("NA", chrpos)) 
ukbb_11 <- ukbb_11[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_11, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr11\\ukbb_2_11.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_12 <- filter(ukbb, grepl("^12:", chrpos)) 
ukbb_12 <- filter(ukbb_12, !grepl("NA", chrpos)) 
ukbb_12 <- ukbb_12[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_12, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr12\\ukbb_2_12.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_13 <- filter(ukbb, grepl("^13:", chrpos)) 
ukbb_13 <- filter(ukbb_13, !grepl("NA", chrpos)) 
ukbb_13 <- ukbb_13[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_13, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr13\\ukbb_2_13.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_14 <- filter(ukbb, grepl("^14:", chrpos)) 
ukbb_14 <- filter(ukbb_14, !grepl("NA", chrpos)) 
ukbb_14 <- ukbb_14[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_14, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr14\\ukbb_2_14.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_15 <- filter(ukbb, grepl("^15:", chrpos)) 
ukbb_15 <- filter(ukbb_15, !grepl("NA", chrpos)) 
ukbb_15 <- ukbb_15[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_15, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr15\\ukbb_2_15.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_16 <- filter(ukbb, grepl("^16:", chrpos)) 
ukbb_16 <- filter(ukbb_16, !grepl("NA", chrpos)) 
ukbb_16 <- ukbb_16[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_16, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr16\\ukbb_2_16.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_17 <- filter(ukbb, grepl("^17:", chrpos)) 
ukbb_17 <- filter(ukbb_17, !grepl("NA", chrpos)) 
ukbb_17 <- ukbb_17[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_17, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr17\\ukbb_2_17.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_18 <- filter(ukbb, grepl("^18:", chrpos)) 
ukbb_18 <- filter(ukbb_18, !grepl("NA", chrpos)) 
ukbb_18 <- ukbb_18[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_18, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr18\\ukbb_2_18.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_19 <- filter(ukbb, grepl("^19:", chrpos)) 
ukbb_19 <- filter(ukbb_19, !grepl("NA", chrpos)) 
ukbb_19 <- ukbb_19[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_19, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr19\\ukbb_2_19.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_20 <- filter(ukbb, grepl("^20:", chrpos)) 
ukbb_20 <- filter(ukbb_20, !grepl("NA", chrpos)) 
ukbb_20 <- ukbb_20[,c(16,13,17,18,9,10,12)] 
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#write.table(ukbb_20, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr20\\ukbb_2_20.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_21 <- filter(ukbb, grepl("^21:", chrpos)) 
ukbb_21 <- filter(ukbb_21, !grepl("NA", chrpos)) 
ukbb_21 <- ukbb_21[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_21, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr21\\ukbb_2_21.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
 
ukbb_22 <- filter(ukbb, grepl("^22:", chrpos)) 
ukbb_22 <- filter(ukbb_22, !grepl("NA", chrpos)) 
ukbb_22 <- ukbb_22[,c(16,13,17,18,9,10,12)] 
#write.table(ukbb_22, sep=",", file="C:\\msys64\\home\\Mark\\METAL\\Chr22\\ukbb_2_22.txt", row.names=FALSE, 
col.names=TRUE, quote=FALSE) 
METAr1_2 <- read.table("META_Chr1_2_1.txt", header=TRUE, sep="\t") 
METAr1_2$chromosome <- 1 
 
METAr2_2 <- read.table("META_Chr2_2_1.txt", header=TRUE, sep="\t") 
METAr2_2$chromosome <- 2 
 
METAr3_2 <- read.table("META_Chr3_2_1.txt", header=TRUE, sep="\t") 
METAr3_2$chromosome <- 3 
 
METAr4_2 <- read.table("META_Chr4_2_1.txt", header=TRUE, sep="\t") 
METAr4_2$chromosome <- 4 
 
METAr5_2 <- read.table("META_Chr5_2_1.txt", header=TRUE, sep="\t") 
METAr5_2$chromosome <- 5 
 
METAr6_2 <- read.table("META_Chr6_2_1.txt", header=TRUE, sep="\t") 
METAr6_2$chromosome <- 6 
 
METAr7_2 <- read.table("META_Chr7_2_1.txt", header=TRUE, sep="\t") 
METAr7_2$chromosome <- 7 
 
METAr8_2 <- read.table("META_Chr8_2_1.txt", header=TRUE, sep="\t") 
METAr8_2$chromosome <- 8 
 
METAr9_2 <- read.table("META_Chr9_2_1.txt", header=TRUE, sep="\t") 
METAr9_2$chromosome <- 9 
 
METAr10_2 <- read.table("META_Chr10_2_1.txt", header=TRUE, sep="\t") 
METAr10_2$chromosome <- 10 
 
METAr11_2 <- read.table("META_Chr11_2_1.txt", header=TRUE, sep="\t") 
METAr11_2$chromosome <- 11 
 
METAr12_2 <- read.table("META_Chr12_2_1.txt", header=TRUE, sep="\t") 
METAr12_2$chromosome <- 12 
 
METAr13_2 <- read.table("META_Chr13_2_1.txt", header=TRUE, sep="\t") 
METAr13_2$chromosome <- 13 
 
METAr14_2 <- read.table("META_Chr14_2_1.txt", header=TRUE, sep="\t") 
METAr14_2$chromosome <- 14 
 
METAr15_2 <- read.table("META_Chr15_2_1.txt", header=TRUE, sep="\t") 
METAr15_2$chromosome <- 15 
 
METAr16_2 <- read.table("META_Chr16_2_1.txt", header=TRUE, sep="\t") 




METAr17_2 <- read.table("META_Chr17_2_1.txt", header=TRUE, sep="\t") 
METAr17_2$chromosome <- 17 
 
METAr18_2 <- read.table("META_Chr18_2_1.txt", header=TRUE, sep="\t") 
METAr18_2$chromosome <- 18 
 
METAr19_2 <- read.table("META_Chr19_2_1.txt", header=TRUE, sep="\t") 
METAr19_2$chromosome <- 19 
 
METAr20_2 <- read.table("META_Chr20_2_1.txt", header=TRUE, sep="\t") 
METAr20_2$chromosome <- 20 
 
METAr21_2 <- read.table("META_Chr21_2_1.txt", header=TRUE, sep="\t") 
METAr21_2$chromosome <- 21 
 
METAr22_2 <- read.table("META_Chr22_2_1.txt", header=TRUE, sep="\t") 
METAr22_2$chromosome <- 22 
 
METAr23 <- read.table("META_Chr23_1.txt", header=TRUE, sep="\t") 
METAr23$chromosome <- 23 
METAr_2 <- rbind(METAr1_2, METAr2_2, METAr3_2, METAr4_2, METAr5_2, METAr6_2, METAr7_2,  
                 METAr8_2, METAr9_2, METAr10_2, METAr11_2, METAr12_2, METAr13_2, 
               METAr14_2, METAr15_2, METAr16_2, METAr17_2, METAr18_2, METAr19_2,  
               METAr20_2, METAr21_2, METAr22_2, METAr23) 
rm(list = c('METAr1_2','METAr2_2','METAr3_2','METAr4_2','METAr5_2','METAr6_2', 
            'METAr7_2','METAr8_2','METAr9_2','METAr10_2','METAr11_2','METAr12_2', 
            'METAr13_2','METAr14_2','METAr15_2','METAr16_2','METAr17_2','METAr18_2', 
            'METAr19_2','METAr20_2','METAr21_2','METAr22_2','METAr23')) 
METAr_2$Position <- gsub("^.*:", "", METAr_2$MarkerName) 
 
METAr_2$chromosome <- as.numeric(METAr_2$chromosome) 
METAr_2$Position <- as.numeric(METAr_2$Position) 
METAr_2 <- arrange(METAr_2, chromosome, Position) 
 
 
#Assessing number of missing underlying studies by marker: 
#Cut down SNPs to just those in at least 2 underlying studies: 
 
 
METAr_2$num_miss <- str_count(as.character(METAr_2$Direction), "\\?") 
METAr_2 <- METAr_2 %>% filter(num_miss < 2) 
 
#write.table(METAr_2, sep="\t", file="C:\\Users\\Mark\\Documents\\METAr_2_filtered.txt", row.names = FALSE, 




#Filtering for significant SNPs: 
METAr_2_sig <- filter(METAr_2, P.value <= 0.00000005) 
METAr_2_sig <- METAr_2_sig[,c(12:13,1:11)] 
 
#Fix one ambiguous allele - 17:46505002 shows "<ins:me:alu>" as an effect allele, 
#which is a generic term for an ALU element insertion. According to dbSNP 
#(https://www.ncbi.nlm.nih.gov/snp/?term=46505002%5BPOSITION_GRCH37%5D+AND+17%5BCHR%5D) 
#alternate allele is G. 
 
METAr_2_sig$Allele1 <- gsub("<ins:me:alu>", "g", METAr_2_sig$Allele1) 
library(metaviz) 
#SNP 9:16913836 - (none present in UKBB ovarian data) 
 
phelan_9 <- read.table("Summary_chr9.txt", header=TRUE, sep=",") 




phelan_9$chrpos <- paste(phelan_9$Chromosome, phelan_9$Position, sep=":") 
lawrenson_9$chrpos <- paste(lawrenson_9$Chromosome, lawrenson_9$Position, sep=":") 
 
phelan_9 <- phelan_9 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_9 <- lawrenson_9 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
 
law9_fp1 <- filter(lawrenson_9, grepl("9:16913836", chrpos)) 
phe9_fp1 <- filter(phelan_9, grepl("9:16913836", chrpos)) 
 
law9_fp1 <- law9_fp1[,c(41,3:7,9,10,12)] 
law9_fp1$study <- "Lawrenson (2019)" 
law9_fp1$N.cases <- 7321 
law9_fp1$N.controls <- 4083 
phe9_fp1 <- phe9_fp1[,c(73,3:7,9:10,12)] 
phe9_fp1$study <- "Phelan (2017)" 
phe9_fp1$N.cases <- 25509 
phe9_fp1$N.controls <- 40941 
 
combined1 <- rbind(law9_fp1, phe9_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_9_fp1 <- filter(METAr_2, chromosome == 9) 
METAr_2_9_fp1 <- filter(METAr_2_9_fp1, grepl("9:16913836", MarkerName)) 
METAr_2_9_fp1$study <- "Meta" 
METAr_2_9_fp1$N.cases <- law9_fp1$N.cases + phe9_fp1$N.cases 
METAr_2_9_fp1$N.controls <- law9_fp1$N.controls + phe9_fp1$N.controls 
METAr_2_9_fp1 <- METAr_2_9_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_2_9_fp1, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 9:16913836", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 3:156481585 
 
phelan_3 <- read.table("Summary_chr3.txt", header=TRUE, sep=",") 
lawrenson_3 <- read.table("SummaryResults_Asian_chr3.txt", header=TRUE, sep=",") 
 
phelan_3$chrpos <- paste(phelan_3$Chromosome, phelan_3$Position, sep=":") 
lawrenson_3$chrpos <- paste(lawrenson_3$Chromosome, lawrenson_3$Position, sep=":") 
 
phelan_3 <- phelan_3 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_3 <- lawrenson_3 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 




law3_fp1 <- filter(lawrenson_3, grepl("3:156481585", chrpos)) 
phe3_fp1 <- filter(phelan_3, grepl("3:156481585", chrpos)) 
phe3_fp1 <- phe3_fp1 %>% filter(Effect == "C") #has two matches, one matches alleles to other 
 
law3_fp1 <- law3_fp1[,c(41,3:7,9,10,12)] 
law3_fp1$study <- "Lawrenson (2019)" 
law3_fp1$N.cases <- 7321 
law3_fp1$N.controls <- 4083 
phe3_fp1 <- phe3_fp1[,c(73,3:7,9:10,12)] 
phe3_fp1$study <- "Phelan (2017)" 
phe3_fp1$N.cases <- 25509 
phe3_fp1$N.controls <- 40941 
 
combined1 <- rbind(law3_fp1, phe3_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_3_fp1 <- filter(METAr_2, chromosome == 3) 
METAr_2_3_fp1 <- filter(METAr_2_3_fp1, grepl("3:156481585", MarkerName)) 
METAr_2_3_fp1$Effect <- -(as.numeric(METAr_2_3_fp1$Effect)) 
 
METAr_2_3_fp1$study <- "Meta" 
METAr_2_3_fp1$N.cases <- law3_fp1$N.cases + phe3_fp1$N.cases 
METAr_2_3_fp1$N.controls <- law3_fp1$N.controls + phe3_fp1$N.controls 
METAr_2_3_fp1 <- METAr_2_3_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
 
combined2 <- merge(combined1, METAr_2_3_fp1, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 3:156481585", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 17:44260644 
 
phelan_17 <- read.table("Summary_chr17.txt", header=TRUE, sep=",") 
lawrenson_17 <- read.table("SummaryResults_Asian_chr17.txt", header=TRUE, sep=",") 
 
phelan_17$chrpos <- paste(phelan_17$Chromosome, phelan_17$Position, sep=":") 
lawrenson_17$chrpos <- paste(lawrenson_17$Chromosome, lawrenson_17$Position, sep=":") 
 
phelan_17 <- phelan_17 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_17 <- lawrenson_17 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
 
law17_fp1 <- filter(lawrenson_17, grepl("17:44260644", chrpos)) 
phe17_fp1 <- filter(phelan_17, grepl("17:44260644", chrpos)) 
 
law17_fp1 <- law17_fp1[,c(41,3:7,9,10,12)] 
law17_fp1$study <- "Lawrenson (2019)" 
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law17_fp1$N.cases <- 7321 
law17_fp1$N.controls <- 4083 
phe17_fp1 <- phe17_fp1[,c(73,3:7,9:10,12)] 
phe17_fp1$study <- "Phelan (2017)" 
phe17_fp1$N.cases <- 25509 
phe17_fp1$N.controls <- 40941 
 
combined1 <- rbind(law17_fp1, phe17_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_17_fp1 <- filter(METAr_2, chromosome == 17) 
METAr_2_17_fp1 <- filter(METAr_2_17_fp1, grepl("17:44260644", MarkerName)) 
METAr_2_17_fp1$study <- "Meta" 
METAr_2_17_fp1$N.cases <- law17_fp1$N.cases + phe17_fp1$N.cases 
METAr_2_17_fp1$N.controls <- law17_fp1$N.controls + phe17_fp1$N.controls 
METAr_2_17_fp1 <- METAr_2_17_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_2_17_fp1, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 17:44260644", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 17:43956139 
 
law17_fp2 <- filter(lawrenson_17, grepl("17:43956139", chrpos)) 
phe17_fp2 <- filter(phelan_17, grepl("17:43956139", chrpos)) 
 
law17_fp2 <- law17_fp2[,c(41,3:7,9,10,12)] 
law17_fp2$study <- "Lawrenson (2019)" 
law17_fp2$N.cases <- 7321 
law17_fp2$N.controls <- 4083 
phe17_fp2 <- phe17_fp2[,c(73,3:7,9:10,12)] 
phe17_fp2$study <- "Phelan (2017)" 
phe17_fp2$N.cases <- 25509 
phe17_fp2$N.controls <- 40941 
 
combined1 <- rbind(law17_fp2, phe17_fp2) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_17_fp2 <- filter(METAr_2, chromosome == 17) 
METAr_2_17_fp2 <- filter(METAr_2_17_fp2, grepl("17:43956139", MarkerName)) 
METAr_2_17_fp2$Effect <- -(as.numeric(METAr_2_17_fp2$Effect)) 
 
METAr_2_17_fp2$study <- "Meta" 
METAr_2_17_fp2$N.cases <- law17_fp2$N.cases + phe17_fp2$N.cases 
METAr_2_17_fp2$N.controls <- law17_fp2$N.controls + phe17_fp2$N.controls 
METAr_2_17_fp2 <- METAr_2_17_fp2 %>% rename(chrpos=MarkerName, log_OR=Effect,  
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                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
 
combined2 <- merge(combined1, METAr_2_17_fp2, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 17:43956139", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 17:44517766 
 
law17_fp3 <- filter(lawrenson_17, grepl("17:44517766", chrpos)) 
phe17_fp3 <- filter(phelan_17, grepl("17:44517766", chrpos)) 
 
law17_fp3 <- law17_fp3[,c(41,3:7,9,10,12)] 
law17_fp3$study <- "Lawrenson (2019)" 
law17_fp3$N.cases <- 7321 
law17_fp3$N.controls <- 4083 
phe17_fp3 <- phe17_fp3[,c(73,3:7,9:10,12)] 
phe17_fp3$study <- "Phelan (2017)" 
phe17_fp3$N.cases <- 25509 
phe17_fp3$N.controls <- 40941 
 
combined1 <- rbind(law17_fp3, phe17_fp3) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_17_fp3 <- filter(METAr_2, chromosome == 17) 
METAr_2_17_fp3 <- filter(METAr_2_17_fp3, grepl("17:44517766", MarkerName)) 
METAr_2_17_fp3$study <- "Meta" 
METAr_2_17_fp3$N.cases <- law17_fp3$N.cases + phe17_fp3$N.cases 
METAr_2_17_fp3$N.controls <- law17_fp3$N.controls + phe17_fp3$N.controls 
METAr_2_17_fp3 <- METAr_2_17_fp3 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_2_17_fp3, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 17:44517766", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 2:176753806 
 
phelan_2 <- read.table("Summary_chr2.txt", header=TRUE, sep=",") 
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lawrenson_2 <- read.table("SummaryResults_Asian_chr2.txt", header=TRUE, sep=",") 
 
phelan_2$chrpos <- paste(phelan_2$Chromosome, phelan_2$Position, sep=":") 
lawrenson_2$chrpos <- paste(lawrenson_2$Chromosome, lawrenson_2$Position, sep=":") 
 
phelan_2 <- phelan_2 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_2 <- lawrenson_2 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
 
law2_fp1 <- filter(lawrenson_2, grepl("2:176753806", chrpos)) 
phe2_fp1 <- filter(phelan_2, grepl("2:176753806", chrpos)) 
 
law2_fp1 <- law2_fp1[,c(41,3:7,9,10,12)] 
law2_fp1$study <- "Lawrenson (2019)" 
law2_fp1$N.cases <- 7321 
law2_fp1$N.controls <- 4083 
phe2_fp1 <- phe2_fp1[,c(73,3:7,9:10,12)] 
phe2_fp1$study <- "Phelan (2017)" 
phe2_fp1$N.cases <- 25509 
phe2_fp1$N.controls <- 40941 
 
combined1 <- rbind(law2_fp1, phe2_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_2_fp1 <- filter(METAr_2, chromosome == 2) 
METAr_2_2_fp1 <- filter(METAr_2_2_fp1, grepl("2:176753806", MarkerName)) 
METAr_2_2_fp1$study <- "Meta" 
METAr_2_2_fp1$N.cases <- law2_fp1$N.cases + phe2_fp1$N.cases 
METAr_2_2_fp1$N.controls <- law2_fp1$N.controls + phe2_fp1$N.controls 
METAr_2_2_fp1 <- METAr_2_2_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_2_2_fp1, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 2:176753806", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 17:46457047 
 
law17_fp4 <- filter(lawrenson_17, grepl("17:46457047", chrpos)) 
phe17_fp4 <- filter(phelan_17, grepl("17:46457047", chrpos)) 
 
law17_fp4 <- law17_fp4[,c(41,3:7,9,10,12)] 
law17_fp4$study <- "Lawrenson (2019)" 
law17_fp4$N.cases <- 7321 
law17_fp4$N.controls <- 4083 
phe17_fp4 <- phe17_fp4[,c(73,3:7,9:10,12)] 
phe17_fp4$study <- "Phelan (2017)" 
phe17_fp4$N.cases <- 25509 
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phe17_fp4$N.controls <- 40941 
 
combined1 <- rbind(law17_fp4, phe17_fp4) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_17_fp4 <- filter(METAr_2, chromosome == 17) 
METAr_2_17_fp4 <- filter(METAr_2_17_fp4, grepl("17:46457047", MarkerName)) 
METAr_2_17_fp4$Effect <- -(as.numeric(METAr_2_17_fp4$Effect)) 
 
METAr_2_17_fp4$study <- "Meta" 
METAr_2_17_fp4$N.cases <- law17_fp4$N.cases + phe17_fp4$N.cases 
METAr_2_17_fp4$N.controls <- law17_fp4$N.controls + phe17_fp4$N.controls 
METAr_2_17_fp4 <- METAr_2_17_fp4 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
 
combined2 <- merge(combined1, METAr_2_17_fp4, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 17:46457047", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 8:129480083 
 
phelan_8 <- read.table("Summary_chr8.txt", header=TRUE, sep=",") 
lawrenson_8 <- read.table("SummaryResults_Asian_chr8.txt", header=TRUE, sep=",") 
 
phelan_8$chrpos <- paste(phelan_8$Chromosome, phelan_8$Position, sep=":") 
lawrenson_8$chrpos <- paste(lawrenson_8$Chromosome, lawrenson_8$Position, sep=":") 
 
phelan_8 <- phelan_8 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_8 <- lawrenson_8 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
 
law8_fp1 <- filter(lawrenson_8, grepl("8:129480083", chrpos)) 
phe8_fp1 <- filter(phelan_8, grepl("8:129480083", chrpos)) 
#Two results, using the SNP used by METAL: 
law8_fp1 <- filter(law8_fp1, Effect == "G") 
phe8_fp1 <- filter(phe8_fp1, Effect == "G") 
 
law8_fp1 <- law8_fp1[,c(41,3:7,9,10,12)] 
law8_fp1$study <- "Lawrenson (2019)" 
law8_fp1$N.cases <- 7321 
law8_fp1$N.controls <- 4083 
phe8_fp1 <- phe8_fp1[,c(73,3:7,9:10,12)] 
phe8_fp1$study <- "Phelan (2017)" 
phe8_fp1$N.cases <- 25509 
phe8_fp1$N.controls <- 40941 
 
combined1 <- rbind(law8_fp1, phe8_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
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combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_8_fp1 <- filter(METAr_2, chromosome == 8) 
METAr_2_8_fp1 <- filter(METAr_2_8_fp1, grepl("8:129480083", MarkerName)) 
METAr_2_8_fp1$study <- "Meta" 
METAr_2_8_fp1$N.cases <- law8_fp1$N.cases + phe8_fp1$N.cases 
METAr_2_8_fp1$N.controls <- law8_fp1$N.controls + phe8_fp1$N.controls 
METAr_2_8_fp1 <- METAr_2_8_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele1, Baseline=Allele2) 
 
combined2 <- merge(combined1, METAr_2_8_fp1, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 8:129480083", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#SNP 19:17374507 
 
phelan_19 <- read.table("Summary_chr19.txt", header=TRUE, sep=",") 
lawrenson_19 <- read.table("SummaryResults_Asian_chr19.txt", header=TRUE, sep=",") 
 
phelan_19$chrpos <- paste(phelan_19$Chromosome, phelan_19$Position, sep=":") 
lawrenson_19$chrpos <- paste(lawrenson_19$Chromosome, lawrenson_19$Position, sep=":") 
 
phelan_19 <- phelan_19 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
lawrenson_19 <- lawrenson_19 %>% filter(EAF > 0.01 & EAF < 0.99) %>% filter(overall_SE > 0) %>% 
                  filter(overall_pvalue > 0 & overall_pvalue < 1) 
 
law19_fp1 <- filter(lawrenson_19, grepl("19:17374507", chrpos)) 
phe19_fp1 <- filter(phelan_19, grepl("19:17374507", chrpos)) 
 
law19_fp1 <- law19_fp1[,c(41,3:7,9,10,12)] 
law19_fp1$study <- "Lawrenson (2019)" 
law19_fp1$N.cases <- 7321 
law19_fp1$N.controls <- 4083 
phe19_fp1 <- phe19_fp1[,c(73,3:7,9:10,12)] 
phe19_fp1$study <- "Phelan (2017)" 
phe19_fp1$N.cases <- 25509 
phe19_fp1$N.controls <- 40941 
 
combined1 <- rbind(law19_fp1, phe19_fp1) 
combined1$EAF <- ifelse(combined1$EAF >= 0.5, 1 - combined1$EAF, combined1$EAF) 
combined1 <- combined1 %>% rename(log_OR=overall_OR, stderr=overall_SE, 
                                  P.value=overall_pvalue, MAF=EAF) 
 
METAr_2_19_fp1 <- filter(METAr_2, chromosome == 19) 
METAr_2_19_fp1 <- filter(METAr_2_19_fp1, grepl("19:17374507", MarkerName)) 
METAr_2_19_fp1$Effect <- -(as.numeric(METAr_2_19_fp1$Effect)) 
 
METAr_2_19_fp1$study <- "Meta" 
METAr_2_19_fp1$N.cases <- law19_fp1$N.cases + phe19_fp1$N.cases 
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METAr_2_19_fp1$N.controls <- law19_fp1$N.controls + phe19_fp1$N.controls 
METAr_2_19_fp1 <- METAr_2_19_fp1 %>% rename(chrpos=MarkerName, log_OR=Effect,  
                                          stderr=StdErr, Effect=Allele2, Baseline=Allele1) 
 
combined2 <- merge(combined1, METAr_2_19_fp1, all=TRUE) 
ordervec <- c("Lawrenson (2019)", "Phelan (2017)", "Meta") 
combined2$study <- factor(combined2$study, levels=ordervec) 
combined2 <- with(combined2, combined2[order(study),]) 
combined2$ncc <- paste(combined2$N.cases, combined2$N.controls, sep="/") 
study.table <- combined2[,c(8,3,4,7,12,20)] 
summary.table <- combined2[, c("log_OR", "stderr")] 
 
viz_forest(summary.table, type="study_only",  
           variant="rain", 
           x_trans_function = exp, 
           xlab="OR SNP 19:17374507", annotate_CI = TRUE,  
           study_table = study.table, 
           table_headers=c("Study", "Effect", "Baseline", "P", "MAF", "NCase/NControl"), 
           table_layout = matrix(c(1,1,2,3), 2, 2, byrow=TRUE)) 
#Make significant results match up with input alleles to determine allele swaps: 
alleleframe <- METAr_2_sig 
phelan_alleles <- rbind(phelan_17,phelan_19,phelan_2,phelan_3,phelan_8,phelan_9) 
alleleframe <- merge(alleleframe, phelan_alleles, by.x="MarkerName", by.y="chrpos", all.x=TRUE) 
alleleframe <- alleleframe[,c(1:13,16:20,22,23,25)] 
alleleframe2 <- alleleframe[,-c(14:15,18:21)] 
alleleframe2 <- alleleframe2 %>% filter(is.na(Effect.y) == FALSE) %>%  
  filter(Effect.y != "GAG") %>% filter(Effect.y != "GTT") 
alleleframe2$Effect.y <- gsub("<INS:ME:ALU>", "G", alleleframe2$Effect.y) 
alleleframe2 <- alleleframe2[,c(1:5,15:14,6:13)] 
 
 
alleleframe2 <- alleleframe2 %>% rename(SNP=MarkerName, `Input Effect Allele` = Effect.y, 
                                        `Input Base Allele` = Baseline, `Output Effect Allele` = Allele1, 
                                        `Output Base Allele` = Allele2, Beta = Effect.x, SE=StdErr, 
                                        `P-Value` = P.value, `Het. I-Squared` = HetISq, `Het. Chi-Squared` = HetChiSq, 
                                        `Het. DF` = HetDf, `Het. P-Value` = HetPVal, Chromosome = chromosome, 
                                        Position = Position.x) 
 
alleleframe2 <- arrange(alleleframe2, alleleframe2$Chromosome, alleleframe2$Position) 
alleleframe2$`Output Effect Allele` <- toupper(alleleframe2$`Output Effect Allele`) 
alleleframe2$`Output Base Allele` <- toupper(alleleframe2$`Output Base Allele`) 
 
alleleframe2_res <- alleleframe2[,c(1:3,6:7,4:5,8:11)] 




stargazer(alleleframe2_res, type="html", summary=FALSE, rownames=FALSE, out="ovarian_meta_results_table.doc",  
          title="Ovarian-Only Meta-Analysis Significant Results") 
stargazer(alleleframe2_het, type="html", summary=FALSE, rownames=FALSE, 
out="ovarian_meta_results_table_2.doc",  
          title="Ovarian-Only Meta-Analysis Significant Results - Heterogeneity Test") 
#Make table for variants lost across flowchart steps: 
#precalculated values 
 
varflow <- data.frame(Study = c("O'Mara (2018)", "Phelan (2017)", "Lawrenson (2019)", "UK Biobank (Cerv., 2018)", 
"UK Biobank (Ovar., 2018)"), 
                      `Number of Variants at Start` = c(9518973,20594648,20246914,13791467,13791467),  
                      `Number After Filtering Nonsense Entries` = c(9518964,20000699,20030609,13788358,13788363), 
                      `Number After Filtering Low Allele Frequency` = c(9518964,10236573,9156543,9664368,9664368)) 
varflow <- varflow %>% rename(`Number of Variants at Start`=Number.of.Variants.at.Start, 
                              `Number After Filtering Nonsense Entries`=Number.After.Filtering.Nonsense.Entries, 
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                              `Number After Filtering Low Allele Frequency`=Number.After.Filtering.Low.Allele.Frequency) 
stargazer(varflow, type="html", summary=FALSE, rownames=FALSE, out="var_flow.doc",  
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